KR20230023267A - Cosmetic composition comprising mixed extrracts of pinus koraiensis wood and kenaf - Google Patents
Cosmetic composition comprising mixed extrracts of pinus koraiensis wood and kenaf Download PDFInfo
- Publication number
- KR20230023267A KR20230023267A KR1020210105234A KR20210105234A KR20230023267A KR 20230023267 A KR20230023267 A KR 20230023267A KR 1020210105234 A KR1020210105234 A KR 1020210105234A KR 20210105234 A KR20210105234 A KR 20210105234A KR 20230023267 A KR20230023267 A KR 20230023267A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- cosmetic composition
- kenaf
- weight
- mixture
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 127
- 240000000797 Hibiscus cannabinus Species 0.000 title claims abstract description 95
- 239000002023 wood Substances 0.000 title claims abstract description 74
- 239000002537 cosmetic Substances 0.000 title claims abstract description 68
- 235000011615 Pinus koraiensis Nutrition 0.000 title claims abstract description 10
- 240000007263 Pinus koraiensis Species 0.000 title claims abstract description 10
- 239000000284 extract Substances 0.000 claims abstract description 204
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims abstract description 102
- 235000011613 Pinus brutia Nutrition 0.000 claims abstract description 102
- 241000018646 Pinus brutia Species 0.000 claims abstract description 102
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 22
- 239000004480 active ingredient Substances 0.000 claims abstract description 17
- 230000002087 whitening effect Effects 0.000 claims abstract description 17
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 16
- 235000015928 Hibiscus cannabinus Nutrition 0.000 claims abstract description 6
- 230000000694 effects Effects 0.000 claims description 52
- -1 serum Substances 0.000 claims description 51
- 230000014509 gene expression Effects 0.000 claims description 41
- 102000003425 Tyrosinase Human genes 0.000 claims description 36
- 108060008724 Tyrosinase Proteins 0.000 claims description 36
- 230000005764 inhibitory process Effects 0.000 claims description 34
- 102100030310 5,6-dihydroxyindole-2-carboxylic acid oxidase Human genes 0.000 claims description 22
- 108010050345 Microphthalmia-Associated Transcription Factor Proteins 0.000 claims description 22
- 102000013760 Microphthalmia-Associated Transcription Factor Human genes 0.000 claims description 22
- 108010051081 dopachrome isomerase Proteins 0.000 claims description 22
- 108010014402 tyrosinase-related protein-1 Proteins 0.000 claims description 22
- 102100031413 L-dopachrome tautomerase Human genes 0.000 claims description 20
- 230000002292 Radical scavenging effect Effects 0.000 claims description 16
- 102000016387 Pancreatic elastase Human genes 0.000 claims description 15
- 108010067372 Pancreatic elastase Proteins 0.000 claims description 15
- 239000006210 lotion Substances 0.000 claims description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 11
- 235000013311 vegetables Nutrition 0.000 claims description 11
- 239000006071 cream Substances 0.000 claims description 10
- 239000000469 ethanolic extract Substances 0.000 claims description 10
- 238000000605 extraction Methods 0.000 claims description 10
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 9
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 9
- 230000037303 wrinkles Effects 0.000 claims description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 8
- 230000006872 improvement Effects 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000011148 porous material Substances 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 6
- 206010061218 Inflammation Diseases 0.000 claims description 6
- 241000241413 Propolis Species 0.000 claims description 6
- 102000019197 Superoxide Dismutase Human genes 0.000 claims description 6
- 108010012715 Superoxide dismutase Proteins 0.000 claims description 6
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 claims description 6
- 239000000839 emulsion Substances 0.000 claims description 6
- 230000004054 inflammatory process Effects 0.000 claims description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 6
- 229940069949 propolis Drugs 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- 230000008602 contraction Effects 0.000 claims description 5
- 229940058015 1,3-butylene glycol Drugs 0.000 claims description 4
- 239000009141 Houttuynia cordata plant extract Substances 0.000 claims description 4
- ZTOJFFHGPLIVKC-CLFAGFIQSA-N abts Chemical compound S/1C2=CC(S(O)(=O)=O)=CC=C2N(CC)C\1=N\N=C1/SC2=CC(S(O)(=O)=O)=CC=C2N1CC ZTOJFFHGPLIVKC-CLFAGFIQSA-N 0.000 claims description 4
- 235000019437 butane-1,3-diol Nutrition 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- 229940059958 centella asiatica extract Drugs 0.000 claims description 4
- 239000000686 essence Substances 0.000 claims description 4
- 229940098324 green tea leaf extract Drugs 0.000 claims description 4
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 claims description 3
- 150000001298 alcohols Chemical class 0.000 claims description 3
- 235000020687 goji berry extract Nutrition 0.000 claims description 3
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims description 3
- 239000007934 lip balm Substances 0.000 claims description 3
- 210000002966 serum Anatomy 0.000 claims description 3
- 239000002453 shampoo Substances 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 239000006260 foam Substances 0.000 claims description 2
- ZTOJFFHGPLIVKC-YAFCTCPESA-N (2e)-3-ethyl-2-[(z)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound S\1C2=CC(S(O)(=O)=O)=CC=C2N(CC)C/1=N/N=C1/SC2=CC(S(O)(=O)=O)=CC=C2N1CC ZTOJFFHGPLIVKC-YAFCTCPESA-N 0.000 claims 1
- 239000010455 vermiculite Substances 0.000 claims 1
- 235000019354 vermiculite Nutrition 0.000 claims 1
- 229910052902 vermiculite Inorganic materials 0.000 claims 1
- 230000001153 anti-wrinkle effect Effects 0.000 abstract description 5
- 235000014571 nuts Nutrition 0.000 description 45
- 210000004027 cell Anatomy 0.000 description 29
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 28
- 238000002835 absorbance Methods 0.000 description 24
- 201000001441 melanoma Diseases 0.000 description 19
- 239000003921 oil Substances 0.000 description 19
- 210000003491 skin Anatomy 0.000 description 19
- 235000019198 oils Nutrition 0.000 description 18
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 16
- 235000006708 antioxidants Nutrition 0.000 description 14
- 238000005259 measurement Methods 0.000 description 14
- 108020004999 messenger RNA Proteins 0.000 description 14
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 13
- 235000014113 dietary fatty acids Nutrition 0.000 description 13
- 239000000194 fatty acid Substances 0.000 description 13
- 229930195729 fatty acid Natural products 0.000 description 13
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 12
- 239000000523 sample Substances 0.000 description 11
- 230000003110 anti-inflammatory effect Effects 0.000 description 10
- 230000002401 inhibitory effect Effects 0.000 description 10
- RTIXKCRFFJGDFG-UHFFFAOYSA-N chrysin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=CC=C1 RTIXKCRFFJGDFG-UHFFFAOYSA-N 0.000 description 9
- 239000003925 fat Substances 0.000 description 9
- 235000019197 fats Nutrition 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 239000012488 sample solution Substances 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 230000003833 cell viability Effects 0.000 description 8
- 238000012790 confirmation Methods 0.000 description 8
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 7
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 7
- 239000000872 buffer Substances 0.000 description 7
- 229920001577 copolymer Polymers 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 230000008099 melanin synthesis Effects 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 239000000049 pigment Substances 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 5
- 239000004909 Moisturizer Substances 0.000 description 5
- 239000004359 castor oil Substances 0.000 description 5
- 235000019438 castor oil Nutrition 0.000 description 5
- 102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 5
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 5
- 230000001333 moisturizer Effects 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 150000003254 radicals Chemical class 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- 244000241872 Lycium chinense Species 0.000 description 4
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 description 4
- 108010016113 Matrix Metalloproteinase 1 Proteins 0.000 description 4
- 208000003351 Melanosis Diseases 0.000 description 4
- 230000000692 anti-sense effect Effects 0.000 description 4
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 4
- 230000001747 exhibiting effect Effects 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 239000001023 inorganic pigment Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 239000012860 organic pigment Substances 0.000 description 4
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 4
- 238000003757 reverse transcription PCR Methods 0.000 description 4
- 230000002441 reversible effect Effects 0.000 description 4
- 229920002545 silicone oil Polymers 0.000 description 4
- 239000000344 soap Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- DHGBAFGZLVRESL-UHFFFAOYSA-N 14-methylpentadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C DHGBAFGZLVRESL-UHFFFAOYSA-N 0.000 description 3
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 3
- DSCFFEYYQKSRSV-UHFFFAOYSA-N 1L-O1-methyl-muco-inositol Natural products COC1C(O)C(O)C(O)C(O)C1O DSCFFEYYQKSRSV-UHFFFAOYSA-N 0.000 description 3
- NYCXYKOXLNBYID-UHFFFAOYSA-N 5,7-Dihydroxychromone Natural products O1C=CC(=O)C=2C1=CC(O)=CC=2O NYCXYKOXLNBYID-UHFFFAOYSA-N 0.000 description 3
- 239000004215 Carbon black (E152) Substances 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 102100036213 Collagen alpha-2(I) chain Human genes 0.000 description 3
- 244000301850 Cupressus sempervirens Species 0.000 description 3
- VJXUJFAZXQOXMJ-UHFFFAOYSA-N D-1-O-Methyl-muco-inositol Natural products CC12C(OC)(C)OC(C)(C)C2CC(=O)C(C23OC2C(=O)O2)(C)C1CCC3(C)C2C=1C=COC=1 VJXUJFAZXQOXMJ-UHFFFAOYSA-N 0.000 description 3
- DSCFFEYYQKSRSV-KLJZZCKASA-N D-pinitol Chemical compound CO[C@@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@H]1O DSCFFEYYQKSRSV-KLJZZCKASA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 206010014970 Ephelides Diseases 0.000 description 3
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 3
- 101000875067 Homo sapiens Collagen alpha-2(I) chain Proteins 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 239000004166 Lanolin Substances 0.000 description 3
- 235000015459 Lycium barbarum Nutrition 0.000 description 3
- 235000015468 Lycium chinense Nutrition 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- FGUBFGWYEYFGRK-HNNXBMFYSA-N Pinocembrin Natural products Cc1cc(C)c2C(=O)C[C@H](Oc2c1)c3ccccc3 FGUBFGWYEYFGRK-HNNXBMFYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000002280 amphoteric surfactant Substances 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 229940043370 chrysin Drugs 0.000 description 3
- 235000015838 chrysin Nutrition 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- KCFYHBSOLOXZIF-UHFFFAOYSA-N dihydrochrysin Natural products COC1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 KCFYHBSOLOXZIF-UHFFFAOYSA-N 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 239000011737 fluorine Substances 0.000 description 3
- 229910052731 fluorine Inorganic materials 0.000 description 3
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 235000019388 lanolin Nutrition 0.000 description 3
- 229940039717 lanolin Drugs 0.000 description 3
- 210000002752 melanocyte Anatomy 0.000 description 3
- 235000021317 phosphate Nutrition 0.000 description 3
- URFCJEUYXNAHFI-ZDUSSCGKSA-N pinocembrin Chemical compound C1([C@@H]2CC(=O)C3=C(O)C=C(C=C3O2)O)=CC=CC=C1 URFCJEUYXNAHFI-ZDUSSCGKSA-N 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 230000002000 scavenging effect Effects 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 2
- KTFPZTCBZNFIPH-UHFFFAOYSA-N 1,2,4-trimethoxy-7h-dibenzo[de,g]quinolin-7-one Chemical compound O=C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C(OC)C=NC1=C32 KTFPZTCBZNFIPH-UHFFFAOYSA-N 0.000 description 2
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 2
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- ZCTQGTTXIYCGGC-UHFFFAOYSA-N Benzyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 ZCTQGTTXIYCGGC-UHFFFAOYSA-N 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 2
- 102000029816 Collagenase Human genes 0.000 description 2
- 108060005980 Collagenase Proteins 0.000 description 2
- 102000005636 Cyclic AMP Response Element-Binding Protein Human genes 0.000 description 2
- 108010045171 Cyclic AMP Response Element-Binding Protein Proteins 0.000 description 2
- 102000008130 Cyclic AMP-Dependent Protein Kinases Human genes 0.000 description 2
- 108010049894 Cyclic AMP-Dependent Protein Kinases Proteins 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 108700039887 Essential Genes Proteins 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 102000013382 Gelatinases Human genes 0.000 description 2
- 108010026132 Gelatinases Proteins 0.000 description 2
- 108060003393 Granulin Proteins 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- 240000007049 Juglans regia Species 0.000 description 2
- 235000009496 Juglans regia Nutrition 0.000 description 2
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 2
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
- 241001532026 Liriope muscari Species 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241000219071 Malvaceae Species 0.000 description 2
- 102100030411 Neutrophil collagenase Human genes 0.000 description 2
- 239000002033 PVDF binder Substances 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 206010064127 Solar lentigo Diseases 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 239000000524 Thiobarbituric Acid Reactive Substance Substances 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 235000015278 beef Nutrition 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 229910002091 carbon monoxide Inorganic materials 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229960002424 collagenase Drugs 0.000 description 2
- 230000001595 contractor effect Effects 0.000 description 2
- RAPXDXJBAYUBHI-UHFFFAOYSA-N decyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCCCCCC RAPXDXJBAYUBHI-UHFFFAOYSA-N 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 239000003974 emollient agent Substances 0.000 description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 2
- 239000010696 ester oil Substances 0.000 description 2
- MVLVMROFTAUDAG-UHFFFAOYSA-N ethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC MVLVMROFTAUDAG-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000004459 forage Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N inositol Chemical compound OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 2
- 229960004705 kojic acid Drugs 0.000 description 2
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- BAGGDUOPTSQTHD-UHFFFAOYSA-N norcepharadione b Chemical compound C1=CC=C2C3=C(OC)C(OC)=CC(C(=O)C(=O)N4)=C3C4=CC2=C1 BAGGDUOPTSQTHD-UHFFFAOYSA-N 0.000 description 2
- 235000019488 nut oil Nutrition 0.000 description 2
- 239000010466 nut oil Substances 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- OQILCOQZDHPEAZ-UHFFFAOYSA-N octyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 2
- 229940049964 oleate Drugs 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- AFDXODALSZRGIH-UHFFFAOYSA-N p-coumaric acid methyl ether Natural products COC1=CC=C(C=CC(O)=O)C=C1 AFDXODALSZRGIH-UHFFFAOYSA-N 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- ZQBAKBUEJOMQEX-UHFFFAOYSA-N phenyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OC1=CC=CC=C1 ZQBAKBUEJOMQEX-UHFFFAOYSA-N 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 229940079877 pyrogallol Drugs 0.000 description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 2
- 235000005493 rutin Nutrition 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 230000036560 skin regeneration Effects 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 229940117986 sulfobetaine Drugs 0.000 description 2
- 239000003760 tallow Substances 0.000 description 2
- YCVPRTHEGLPYPB-VOTSOKGWSA-N trans-pinosylvin Chemical compound OC1=CC(O)=CC(\C=C\C=2C=CC=CC=2)=C1 YCVPRTHEGLPYPB-VOTSOKGWSA-N 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 235000020234 walnut Nutrition 0.000 description 2
- 229920003169 water-soluble polymer Polymers 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- 235000014692 zinc oxide Nutrition 0.000 description 2
- WFXHUBZUIFLWCV-UHFFFAOYSA-N (2,2-dimethyl-3-octanoyloxypropyl) octanoate Chemical compound CCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCC WFXHUBZUIFLWCV-UHFFFAOYSA-N 0.000 description 1
- DEQUKPCANKRTPZ-UHFFFAOYSA-N (2,3-dihydroxyphenyl)-phenylmethanone Chemical compound OC1=CC=CC(C(=O)C=2C=CC=CC=2)=C1O DEQUKPCANKRTPZ-UHFFFAOYSA-N 0.000 description 1
- BOCBOJPUWMTAJB-UHFFFAOYSA-N (2-butylphenyl) 2-hydroxybenzoate Chemical compound CCCCC1=CC=CC=C1OC(=O)C1=CC=CC=C1O BOCBOJPUWMTAJB-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- OVYMWJFNQQOJBU-UHFFFAOYSA-N 1-octanoyloxypropan-2-yl octanoate Chemical compound CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCC OVYMWJFNQQOJBU-UHFFFAOYSA-N 0.000 description 1
- GLXBPZNFNSLJBS-UHFFFAOYSA-N 11-methyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCCCCCCCCC(C)C GLXBPZNFNSLJBS-UHFFFAOYSA-N 0.000 description 1
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 1
- OUZOBPPZPCBJAR-UHFFFAOYSA-N 14-methylpentadecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C OUZOBPPZPCBJAR-UHFFFAOYSA-N 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- YICVJSOYNBZJAK-UHFFFAOYSA-N 14-methylpentadecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C YICVJSOYNBZJAK-UHFFFAOYSA-N 0.000 description 1
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 1
- SAMYFBLRCRWESN-UHFFFAOYSA-N 16-methylheptadecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC(C)C SAMYFBLRCRWESN-UHFFFAOYSA-N 0.000 description 1
- MVUWRLHKGKEGSS-UHFFFAOYSA-N 16-methylheptadecyl octanoate Chemical compound CCCCCCCC(=O)OCCCCCCCCCCCCCCCC(C)C MVUWRLHKGKEGSS-UHFFFAOYSA-N 0.000 description 1
- VRBHTEGUHVNKEA-UHFFFAOYSA-N 16-methylheptadecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC(C)C VRBHTEGUHVNKEA-UHFFFAOYSA-N 0.000 description 1
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 1
- FUTGDWNFCMWSJT-UHFFFAOYSA-N 2,3-bis(14-methylpentadecanoyloxy)propyl 14-methylpentadecanoate Chemical compound CC(C)CCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCC(C)C FUTGDWNFCMWSJT-UHFFFAOYSA-N 0.000 description 1
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 2,3-dimethylbutane Chemical group CC(C)C(C)C ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 0.000 description 1
- KIHBGTRZFAVZRV-UHFFFAOYSA-N 2-Hydroxyoctadecanoic acid Natural products CCCCCCCCCCCCCCCCC(O)C(O)=O KIHBGTRZFAVZRV-UHFFFAOYSA-N 0.000 description 1
- IMWRTDKZVXEHLE-QGZVFWFLSA-N 2-[[5-chloro-2-[2-methoxy-4-[(3r)-3-(methylamino)pyrrolidin-1-yl]anilino]pyrimidin-4-yl]amino]-n-propan-2-ylbenzenesulfonamide Chemical compound C1[C@H](NC)CCN1C(C=C1OC)=CC=C1NC1=NC=C(Cl)C(NC=2C(=CC=CC=2)S(=O)(=O)NC(C)C)=N1 IMWRTDKZVXEHLE-QGZVFWFLSA-N 0.000 description 1
- VKUYLANQOAKALN-UHFFFAOYSA-N 2-[benzyl-(4-methoxyphenyl)sulfonylamino]-n-hydroxy-4-methylpentanamide Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)N(C(CC(C)C)C(=O)NO)CC1=CC=CC=C1 VKUYLANQOAKALN-UHFFFAOYSA-N 0.000 description 1
- QUBNFZFTFXTLKH-UHFFFAOYSA-N 2-aminododecanoic acid Chemical compound CCCCCCCCCCC(N)C(O)=O QUBNFZFTFXTLKH-UHFFFAOYSA-N 0.000 description 1
- AKVBCGQVQXPRLD-UHFFFAOYSA-N 2-aminooctanoic acid Chemical compound CCCCCCC(N)C(O)=O AKVBCGQVQXPRLD-UHFFFAOYSA-N 0.000 description 1
- NFIHXTUNNGIYRF-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCCC NFIHXTUNNGIYRF-UHFFFAOYSA-N 0.000 description 1
- GLCFQKXOQDQJFZ-UHFFFAOYSA-N 2-ethylhexyl 12-hydroxyoctadecanoate Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)OCC(CC)CCCC GLCFQKXOQDQJFZ-UHFFFAOYSA-N 0.000 description 1
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- LVYLCBNXHHHPSB-UHFFFAOYSA-N 2-hydroxyethyl salicylate Chemical compound OCCOC(=O)C1=CC=CC=C1O LVYLCBNXHHHPSB-UHFFFAOYSA-N 0.000 description 1
- LEEDMQGKBNGPDN-UHFFFAOYSA-N 2-methylnonadecane Chemical compound CCCCCCCCCCCCCCCCCC(C)C LEEDMQGKBNGPDN-UHFFFAOYSA-N 0.000 description 1
- HTNFLUQQANUSLR-UHFFFAOYSA-N 2-octanoyloxyethyl octanoate Chemical compound CCCCCCCC(=O)OCCOC(=O)CCCCCCC HTNFLUQQANUSLR-UHFFFAOYSA-N 0.000 description 1
- GECRRQVLQHRVNH-MRCUWXFGSA-N 2-octyldodecyl (z)-octadec-9-enoate Chemical compound CCCCCCCCCCC(CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC GECRRQVLQHRVNH-MRCUWXFGSA-N 0.000 description 1
- PTPDZZWUOHQSLG-UHFFFAOYSA-N 2-octyldodecyl 2,2-dimethylpropanoate Chemical compound CCCCCCCCCCC(COC(=O)C(C)(C)C)CCCCCCCC PTPDZZWUOHQSLG-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- QULIOZDJZXKLNY-UHFFFAOYSA-N 3,4,5-trihydroxy-2-propylbenzoic acid Chemical compound CCCC1=C(O)C(O)=C(O)C=C1C(O)=O QULIOZDJZXKLNY-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- YPIFGDQKSSMYHQ-UHFFFAOYSA-M 7,7-dimethyloctanoate Chemical compound CC(C)(C)CCCCCC([O-])=O YPIFGDQKSSMYHQ-UHFFFAOYSA-M 0.000 description 1
- ODMZDMMTKHXXKA-QXMHVHEDSA-N 8-methylnonyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCCCCCCC(C)C ODMZDMMTKHXXKA-QXMHVHEDSA-N 0.000 description 1
- QZCLKYGREBVARF-UHFFFAOYSA-N Acetyl tributyl citrate Chemical compound CCCCOC(=O)CC(C(=O)OCCCC)(OC(C)=O)CC(=O)OCCCC QZCLKYGREBVARF-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 235000006667 Aleurites moluccana Nutrition 0.000 description 1
- 244000136475 Aleurites moluccana Species 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- KPVDACWQNCRKTG-UHFFFAOYSA-N Aristololactam II Natural products C=1C(C(=O)N2)=C3C2=CC2=CC=CC=C2C3=C2OCOC2=1 KPVDACWQNCRKTG-UHFFFAOYSA-N 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 238000009020 BCA Protein Assay Kit Methods 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- JIAVUMAJCIDZOU-UHFFFAOYSA-N CCCCCCCCCC(CCCCCC)OC(=O)CCCCCC(C)(C)C Chemical compound CCCCCCCCCC(CCCCCC)OC(=O)CCCCCC(C)(C)C JIAVUMAJCIDZOU-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical compound NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 235000004032 Centella asiatica Nutrition 0.000 description 1
- 244000146462 Centella asiatica Species 0.000 description 1
- DBNFUUYMTAGFDM-UHFFFAOYSA-N Cepharadione B Natural products C1=CC=C2C3=C(OC)C(OC)=CC(C(=O)C(=O)N4)=C3C4=C(Cl)C2=C1 DBNFUUYMTAGFDM-UHFFFAOYSA-N 0.000 description 1
- AFKGBLKLNRDQFN-UHFFFAOYSA-N Cepharadione B Chemical compound C1=CC=C2C3=C(OC)C(OC)=CC(C(=O)C(=O)N4C)=C3C4=CC2=C1 AFKGBLKLNRDQFN-UHFFFAOYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 240000000491 Corchorus aestuans Species 0.000 description 1
- 235000011777 Corchorus aestuans Nutrition 0.000 description 1
- 235000010862 Corchorus capsularis Nutrition 0.000 description 1
- 239000000055 Corticotropin-Releasing Hormone Substances 0.000 description 1
- 241000496419 Crotalaria cunninghamii Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 241001337225 Daucus carota subsp. carota Species 0.000 description 1
- RDOFJDLLWVCMRU-UHFFFAOYSA-N Diisobutyl adipate Chemical compound CC(C)COC(=O)CCCCC(=O)OCC(C)C RDOFJDLLWVCMRU-UHFFFAOYSA-N 0.000 description 1
- AHMIDUVKSGCHAU-UHFFFAOYSA-N Dopaquinone Natural products OC(=O)C(N)CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-UHFFFAOYSA-N 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- PYVHTIWHNXTVPF-UHFFFAOYSA-N F.F.F.F.C=C Chemical compound F.F.F.F.C=C PYVHTIWHNXTVPF-UHFFFAOYSA-N 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000016622 Filipendula ulmaria Nutrition 0.000 description 1
- 244000061544 Filipendula vulgaris Species 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- 235000005206 Hibiscus Nutrition 0.000 description 1
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 description 1
- 244000284380 Hibiscus rosa sinensis Species 0.000 description 1
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- SHBUUTHKGIVMJT-UHFFFAOYSA-N Hydroxystearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OO SHBUUTHKGIVMJT-UHFFFAOYSA-N 0.000 description 1
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical compound [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- HGNRJCINZYHNOU-LURJTMIESA-N Lys-Gly Chemical compound NCCCC[C@H](N)C(=O)NCC(O)=O HGNRJCINZYHNOU-LURJTMIESA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 231100000002 MTT assay Toxicity 0.000 description 1
- 238000000134 MTT assay Methods 0.000 description 1
- WYQVAPGDARQUBT-FGWHUCSPSA-N Madecassol Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(CC[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O WYQVAPGDARQUBT-FGWHUCSPSA-N 0.000 description 1
- 241001503485 Mammuthus Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 239000004640 Melamine resin Substances 0.000 description 1
- 229920000877 Melamine resin Polymers 0.000 description 1
- 108010008364 Melanocortins Proteins 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- 108010057466 NF-kappa B Proteins 0.000 description 1
- 102000003945 NF-kappa B Human genes 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 108030001564 Neutrophil collagenases Proteins 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- GWFGDXZQZYMSMJ-UHFFFAOYSA-N Octadecansaeure-heptadecylester Natural products CCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCCCC GWFGDXZQZYMSMJ-UHFFFAOYSA-N 0.000 description 1
- RJECHNNFRHZQKU-UHFFFAOYSA-N Oelsaeurecholesterylester Natural products C12CCC3(C)C(C(C)CCCC(C)C)CCC3C2CC=C2C1(C)CCC(OC(=O)CCCCCCCC=CCCCCCCCC)C2 RJECHNNFRHZQKU-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- XACHQDDXHDTRLX-XLVVAOPESA-N Physalien Chemical compound CC1(C)C[C@H](OC(=O)CCCCCCCCCCCCCCC)CC(C)=C1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C[C@@H](OC(=O)CCCCCCCCCCCCCCC)CC1(C)C XACHQDDXHDTRLX-XLVVAOPESA-N 0.000 description 1
- XACHQDDXHDTRLX-GMPBGBGESA-N Physalien Natural products O=C(O[C@H]1CC(C)(C)C(/C=C/C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/C=2C(C)(C)C[C@H](OC(=O)CCCCCCCCCCCCCCC)CC=2C)\C)/C)\C)/C)=C(C)C1)CCCCCCCCCCCCCCC XACHQDDXHDTRLX-GMPBGBGESA-N 0.000 description 1
- 241000218641 Pinaceae Species 0.000 description 1
- KBGNBPGXVKPRQI-UHFFFAOYSA-N Piperolactam A Chemical compound C1=CC=C2C3=C(O)C(OC)=CC(C(=O)N4)=C3C4=CC2=C1 KBGNBPGXVKPRQI-UHFFFAOYSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- NKSOSPOXQKNIKJ-CLFAGFIQSA-N Polyoxyethylene dioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCOC(=O)CCCCCCC\C=C/CCCCCCCC NKSOSPOXQKNIKJ-CLFAGFIQSA-N 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 206010036229 Post inflammatory pigmentation change Diseases 0.000 description 1
- 108010050808 Procollagen Proteins 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- LUJAXSNNYBCFEE-UHFFFAOYSA-N Quercetin 3,7-dimethyl ether Natural products C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C(O)=C1 LUJAXSNNYBCFEE-UHFFFAOYSA-N 0.000 description 1
- PUTDIROJWHRSJW-UHFFFAOYSA-N Quercitrin Natural products CC1OC(Oc2cc(cc(O)c2O)C3=CC(=O)c4c(O)cc(O)cc4O3)C(O)C(O)C1O PUTDIROJWHRSJW-UHFFFAOYSA-N 0.000 description 1
- 239000012083 RIPA buffer Substances 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- 102100030416 Stromelysin-1 Human genes 0.000 description 1
- 101710108790 Stromelysin-1 Proteins 0.000 description 1
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Natural products C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- 229920001807 Urea-formaldehyde Polymers 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- XACHQDDXHDTRLX-UHFFFAOYSA-N Zeaxanthin-dipalmitat Natural products CC1(C)CC(OC(=O)CCCCCCCCCCCCCCC)CC(C)=C1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)CC(OC(=O)CCCCCCCCCCCCCCC)CC1(C)C XACHQDDXHDTRLX-UHFFFAOYSA-N 0.000 description 1
- PRLUQOOFPFWUKQ-KKTNLPSRSA-N [(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl] (z)-octadec-9-enoate Chemical compound C1C[C@@H]2[C@@]3(C)CC[C@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)C[C@@H]3CC[C@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@]21C PRLUQOOFPFWUKQ-KKTNLPSRSA-N 0.000 description 1
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 1
- JBBRZDLNVILTDL-XNTGVSEISA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 16-methylheptadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCCCCCC(C)C)C1 JBBRZDLNVILTDL-XNTGVSEISA-N 0.000 description 1
- WUBKCBOQNXUQDU-UHFFFAOYSA-N [2-(dihydroxymethoxy)phenyl]-phenylmethanone Chemical compound OC(O)OC1=CC=CC=C1C(=O)C1=CC=CC=C1 WUBKCBOQNXUQDU-UHFFFAOYSA-N 0.000 description 1
- SVRHJWALMLOXMI-UHFFFAOYSA-N [2-(dihydroxymethoxy)phenyl]-phenylmethanone;sodium Chemical compound [Na].OC(O)OC1=CC=CC=C1C(=O)C1=CC=CC=C1 SVRHJWALMLOXMI-UHFFFAOYSA-N 0.000 description 1
- YRXGUZPUZBCGST-UHFFFAOYSA-N [2-(hydroxymethoxy)phenyl]-phenylmethanone Chemical compound OCOC1=CC=CC=C1C(=O)C1=CC=CC=C1 YRXGUZPUZBCGST-UHFFFAOYSA-N 0.000 description 1
- KSHPUQQHKKJVIO-UHFFFAOYSA-N [Na].[Zn] Chemical compound [Na].[Zn] KSHPUQQHKKJVIO-UHFFFAOYSA-N 0.000 description 1
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical compound C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 description 1
- OXGUCUVFOIWWQJ-XIMSSLRFSA-N acanthophorin B Natural products O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-XIMSSLRFSA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 229940045714 alkyl sulfonate alkylating agent Drugs 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 229930187117 aristolactam Natural products 0.000 description 1
- MXOKGWUJNGEKBH-UHFFFAOYSA-N aristololactam Chemical compound COC1=CC=CC(C2=C34)=C1C=C3NC(=O)C4=CC1=C2OCO1 MXOKGWUJNGEKBH-UHFFFAOYSA-N 0.000 description 1
- JXSVIVRDWWRQRT-UYDOISQJSA-N asiatic acid Chemical compound C1[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C JXSVIVRDWWRQRT-UYDOISQJSA-N 0.000 description 1
- 229940011658 asiatic acid Drugs 0.000 description 1
- LBGFKBYMNRAMFC-PYSQTNCISA-N asiatic acid Natural products C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@@]34C)[C@]2(C)[C@H]1C)C(=O)O LBGFKBYMNRAMFC-PYSQTNCISA-N 0.000 description 1
- WYQVAPGDARQUBT-XCWYDTOWSA-N asiaticoside Natural products O=C(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@H](O)[C@H](O)[C@H](O[C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)[C@@H](CO)O2)O1)[C@@]12[C@@H]([C@@H](C)[C@H](C)CC1)C=1[C@](C)([C@@]3(C)[C@@H]([C@@]4(C)[C@H]([C@@](CO)(C)[C@@H](O)[C@H](O)C4)CC3)CC=1)CC2 WYQVAPGDARQUBT-XCWYDTOWSA-N 0.000 description 1
- 229940022757 asiaticoside Drugs 0.000 description 1
- QCYLIQBVLZBPNK-UHFFFAOYSA-N asiaticoside A Natural products O1C(C(=O)C(C)C)=CC(C)C(C2(C(OC(C)=O)CC34C5)C)C1CC2(C)C3CCC(C1(C)C)C45CCC1OC1OCC(O)C(O)C1O QCYLIQBVLZBPNK-UHFFFAOYSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960001716 benzalkonium Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- CYDRXTMLKJDRQH-UHFFFAOYSA-N benzododecinium Chemical class CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 CYDRXTMLKJDRQH-UHFFFAOYSA-N 0.000 description 1
- 239000001518 benzyl (E)-3-phenylprop-2-enoate Substances 0.000 description 1
- NGHOLYJTSCBCGC-QXMHVHEDSA-N benzyl cinnamate Chemical compound C=1C=CC=CC=1\C=C/C(=O)OCC1=CC=CC=C1 NGHOLYJTSCBCGC-QXMHVHEDSA-N 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 102000023732 binding proteins Human genes 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229920000704 biodegradable plastic Polymers 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- WMNULTDOANGXRT-UHFFFAOYSA-N bis(2-ethylhexyl) butanedioate Chemical compound CCCCC(CC)COC(=O)CCC(=O)OCC(CC)CCCC WMNULTDOANGXRT-UHFFFAOYSA-N 0.000 description 1
- 229940073609 bismuth oxychloride Drugs 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- DHAZIUXMHRHVMP-UHFFFAOYSA-N butyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCC DHAZIUXMHRHVMP-UHFFFAOYSA-N 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 229940105847 calamine Drugs 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- AGNCRIYGRWNVIF-UHFFFAOYSA-N calcium;2-(dodecanoylamino)acetic acid Chemical compound [Ca].CCCCCCCCCCCC(=O)NCC(O)=O AGNCRIYGRWNVIF-UHFFFAOYSA-N 0.000 description 1
- CEGYXKLZALIAEI-UHFFFAOYSA-N calcium;2-(dodecanoylamino)ethanesulfonic acid Chemical compound [Ca].CCCCCCCCCCCC(=O)NCCS(O)(=O)=O CEGYXKLZALIAEI-UHFFFAOYSA-N 0.000 description 1
- YEFORLIOCBRMFS-UHFFFAOYSA-N calcium;2-(hexadecanoylamino)ethanesulfonic acid Chemical compound [Ca].CCCCCCCCCCCCCCCC(=O)NCCS(O)(=O)=O YEFORLIOCBRMFS-UHFFFAOYSA-N 0.000 description 1
- HOQGRRFKKLWWOO-UHFFFAOYSA-N calcium;3-(dodecanoylamino)propanoic acid Chemical compound [Ca].CCCCCCCCCCCC(=O)NCCC(O)=O HOQGRRFKKLWWOO-UHFFFAOYSA-N 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- SHZIWNPUGXLXDT-UHFFFAOYSA-N caproic acid ethyl ester Natural products CCCCCC(=O)OCC SHZIWNPUGXLXDT-UHFFFAOYSA-N 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000001840 cholesterol esters Chemical class 0.000 description 1
- XHRPOTDGOASDJS-UHFFFAOYSA-N cholesterol n-octadecanoate Natural products C12CCC3(C)C(C(C)CCCC(C)C)CCC3C2CC=C2C1(C)CCC(OC(=O)CCCCCCCCCCCCCCCCC)C2 XHRPOTDGOASDJS-UHFFFAOYSA-N 0.000 description 1
- 229940072104 cholesteryl hydroxystearate Drugs 0.000 description 1
- 229940073724 cholesteryl isostearate Drugs 0.000 description 1
- RJECHNNFRHZQKU-RMUVNZEASA-N cholesteryl oleate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)C1 RJECHNNFRHZQKU-RMUVNZEASA-N 0.000 description 1
- XHRPOTDGOASDJS-XNTGVSEISA-N cholesteryl stearate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCCCCCCCC)C1 XHRPOTDGOASDJS-XNTGVSEISA-N 0.000 description 1
- 229910000423 chromium oxide Inorganic materials 0.000 description 1
- VQWFNAGFNGABOH-UHFFFAOYSA-K chromium(iii) hydroxide Chemical compound [OH-].[OH-].[OH-].[Cr+3] VQWFNAGFNGABOH-UHFFFAOYSA-K 0.000 description 1
- NGHOLYJTSCBCGC-UHFFFAOYSA-N cis-cinnamic acid benzyl ester Natural products C=1C=CC=CC=1C=CC(=O)OCC1=CC=CC=C1 NGHOLYJTSCBCGC-UHFFFAOYSA-N 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 229910052570 clay Inorganic materials 0.000 description 1
- 210000003022 colostrum Anatomy 0.000 description 1
- 235000021277 colostrum Nutrition 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 1
- 229960000258 corticotropin Drugs 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- BOUIEBMBWBCUPB-UHFFFAOYSA-N decyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCCCCCCCC BOUIEBMBWBCUPB-UHFFFAOYSA-N 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 229940031769 diisobutyl adipate Drugs 0.000 description 1
- 229940031569 diisopropyl sebacate Drugs 0.000 description 1
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 1
- MIMDHDXOBDPUQW-UHFFFAOYSA-N dioctyl decanedioate Chemical compound CCCCCCCCOC(=O)CCCCCCCCC(=O)OCCCCCCCC MIMDHDXOBDPUQW-UHFFFAOYSA-N 0.000 description 1
- MHUWZNTUIIFHAS-CLFAGFIQSA-N dioleoyl phosphatidic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-CLFAGFIQSA-N 0.000 description 1
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 description 1
- WPUMTJGUQUYPIV-JIZZDEOASA-L disodium (S)-malate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](O)CC([O-])=O WPUMTJGUQUYPIV-JIZZDEOASA-L 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 239000004664 distearyldimethylammonium chloride (DHTDMAC) Substances 0.000 description 1
- CDIPRYKTRRRSEM-UHFFFAOYSA-M docosyl(trimethyl)azanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCCCCCCCCCC[N+](C)(C)C CDIPRYKTRRRSEM-UHFFFAOYSA-M 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- QQQMUBLXDAFBRH-UHFFFAOYSA-N dodecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)O QQQMUBLXDAFBRH-UHFFFAOYSA-N 0.000 description 1
- VJNCICVKUHKIIV-UHFFFAOYSA-N dopachrome Chemical compound O=C1C(=O)C=C2NC(C(=O)O)CC2=C1 VJNCICVKUHKIIV-UHFFFAOYSA-N 0.000 description 1
- MCPKSFINULVDNX-UHFFFAOYSA-N drometrizole Chemical compound CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 MCPKSFINULVDNX-UHFFFAOYSA-N 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- CLXOLTFMHAXJST-UHFFFAOYSA-N esculentic acid Natural products C12CC=C3C4CC(C)(C(O)=O)CCC4(C(O)=O)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(CO)C CLXOLTFMHAXJST-UHFFFAOYSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- HPMLGOFBKNGJAM-ONEGZZNKSA-N ethyl (e)-3-(1h-imidazol-5-yl)prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CN=CN1 HPMLGOFBKNGJAM-ONEGZZNKSA-N 0.000 description 1
- FMMOOAYVCKXGMF-MURFETPASA-N ethyl linoleate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OCC FMMOOAYVCKXGMF-MURFETPASA-N 0.000 description 1
- 229940031016 ethyl linoleate Drugs 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229960002389 glycol salicylate Drugs 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910052864 hemimorphite Inorganic materials 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 1
- QAKXLTNAJLFSQC-UHFFFAOYSA-N hexadecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC QAKXLTNAJLFSQC-UHFFFAOYSA-N 0.000 description 1
- FPMPNVIMFPEKRN-UHFFFAOYSA-N hexyl 16-methylheptadecanoate Chemical compound CCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C FPMPNVIMFPEKRN-UHFFFAOYSA-N 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 description 1
- 229940072106 hydroxystearate Drugs 0.000 description 1
- 150000002462 imidazolines Chemical class 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 229940078568 isocetyl myristate Drugs 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- 229940093629 isopropyl isostearate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- OVSQVDMCBVZWGM-QCKGUQPXSA-N isoquercetin Natural products OC[C@@H]1O[C@@H](OC2=C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)[C@H](O)[C@@H](O)[C@@H]1O OVSQVDMCBVZWGM-QCKGUQPXSA-N 0.000 description 1
- 229940060384 isostearyl isostearate Drugs 0.000 description 1
- 229940113915 isostearyl palmitate Drugs 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 229960004502 levodopa Drugs 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229940049918 linoleate Drugs 0.000 description 1
- FMMOOAYVCKXGMF-UHFFFAOYSA-N linoleic acid ethyl ester Natural products CCCCCC=CCC=CCCCCCCCC(=O)OCC FMMOOAYVCKXGMF-UHFFFAOYSA-N 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 108010064235 lysylglycine Proteins 0.000 description 1
- PRAUVHZJPXOEIF-AOLYGAPISA-N madecassic acid Chemical compound C1[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]2[C@H](O)C[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C PRAUVHZJPXOEIF-AOLYGAPISA-N 0.000 description 1
- 229940011656 madecassic acid Drugs 0.000 description 1
- BUWCHLVSSFQLPN-UHFFFAOYSA-N madecassic acid Natural products CC1CCC2(CCC3(C)C(=CCC4C5(C)CC(O)C(O)C(C)(C5CCC34C)C(=O)O)C2C1C)C(=O)OC6OC(COC7OC(CO)C(OC8OC(C)C(O)C(O)C8O)C(O)C7O)C(O)C(O)C6O BUWCHLVSSFQLPN-UHFFFAOYSA-N 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- ZADYMNAVLSWLEQ-UHFFFAOYSA-N magnesium;oxygen(2-);silicon(4+) Chemical compound [O-2].[O-2].[O-2].[Mg+2].[Si+4] ZADYMNAVLSWLEQ-UHFFFAOYSA-N 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000002865 melanocortin Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- LAQFLZHBVPULPL-UHFFFAOYSA-N methyl(phenyl)silicon Chemical compound C[Si]C1=CC=CC=C1 LAQFLZHBVPULPL-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 229960002900 methylcellulose Drugs 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- KKBOOQDFOWZSDC-UHFFFAOYSA-N n-[2-(diethylamino)ethyl]octadecanamide Chemical class CCCCCCCCCCCCCCCCCC(=O)NCCN(CC)CC KKBOOQDFOWZSDC-UHFFFAOYSA-N 0.000 description 1
- WWVIUVHFPSALDO-UHFFFAOYSA-N n-[3-(dimethylamino)propyl]octadecanamide Chemical class CCCCCCCCCCCCCCCCCC(=O)NCCCN(C)C WWVIUVHFPSALDO-UHFFFAOYSA-N 0.000 description 1
- VAMFXQBUQXONLZ-UHFFFAOYSA-N n-alpha-eicosene Natural products CCCCCCCCCCCCCCCCCCC=C VAMFXQBUQXONLZ-UHFFFAOYSA-N 0.000 description 1
- GQEZCXVZFLOKMC-UHFFFAOYSA-N n-alpha-hexadecene Natural products CCCCCCCCCCCCCCC=C GQEZCXVZFLOKMC-UHFFFAOYSA-N 0.000 description 1
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- NKBWPOSQERPBFI-UHFFFAOYSA-N octadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCCCC NKBWPOSQERPBFI-UHFFFAOYSA-N 0.000 description 1
- KSCKTBJJRVPGKM-UHFFFAOYSA-N octan-1-olate;titanium(4+) Chemical compound [Ti+4].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-] KSCKTBJJRVPGKM-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- YPMOZWCBANATQH-UHFFFAOYSA-N octyl 7-methyloctanoate Chemical compound CCCCCCCCOC(=O)CCCCCC(C)C YPMOZWCBANATQH-UHFFFAOYSA-N 0.000 description 1
- IIGMITQLXAGZTL-UHFFFAOYSA-N octyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCC IIGMITQLXAGZTL-UHFFFAOYSA-N 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 229940048862 octyldodecyl neopentanoate Drugs 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000010702 perfluoropolyether Substances 0.000 description 1
- 239000005011 phenolic resin Substances 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 229960000969 phenyl salicylate Drugs 0.000 description 1
- LYKRPDCJKSXAHS-UHFFFAOYSA-N phenyl-(2,3,4,5-tetrahydroxyphenyl)methanone Chemical compound OC1=C(O)C(O)=CC(C(=O)C=2C=CC=CC=2)=C1O LYKRPDCJKSXAHS-UHFFFAOYSA-N 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 231100000760 phototoxic Toxicity 0.000 description 1
- SUYJZKRQHBQNCA-LSDHHAIUSA-N pinobanksin Chemical compound C1([C@@H]2[C@H](C(C3=C(O)C=C(O)C=C3O2)=O)O)=CC=CC=C1 SUYJZKRQHBQNCA-LSDHHAIUSA-N 0.000 description 1
- SUYJZKRQHBQNCA-UHFFFAOYSA-N pinobanksin Natural products O1C2=CC(O)=CC(O)=C2C(=O)C(O)C1C1=CC=CC=C1 SUYJZKRQHBQNCA-UHFFFAOYSA-N 0.000 description 1
- YCVPRTHEGLPYPB-UHFFFAOYSA-N pinosylvine Natural products OC1=CC(O)=CC(C=CC=2C=CC=CC=2)=C1 YCVPRTHEGLPYPB-UHFFFAOYSA-N 0.000 description 1
- KOHJULKXWHILSZ-UHFFFAOYSA-N piperolactam A Natural products COc1cc2C(=O)Nc3cc4ccc(O)cc4c(c1)c23 KOHJULKXWHILSZ-UHFFFAOYSA-N 0.000 description 1
- IUGYQRQAERSCNH-UHFFFAOYSA-M pivalate Chemical compound CC(C)(C)C([O-])=O IUGYQRQAERSCNH-UHFFFAOYSA-M 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 108010064470 polyaspartate Proteins 0.000 description 1
- 229920005668 polycarbonate resin Polymers 0.000 description 1
- 239000004431 polycarbonate resin Substances 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- XEIOPEQGDSYOIH-MURFETPASA-N propan-2-yl (9z,12z)-octadeca-9,12-dienoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC(C)C XEIOPEQGDSYOIH-MURFETPASA-N 0.000 description 1
- NEOZOXKVMDBOSG-UHFFFAOYSA-N propan-2-yl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C NEOZOXKVMDBOSG-UHFFFAOYSA-N 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 229940116422 propylene glycol dicaprate Drugs 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 description 1
- OEKUVLQNKPXSOY-UHFFFAOYSA-N quercetin 3-O-beta-D-glucopyranosyl(1->3)-alpha-L-rhamnopyranosyl(1->6)-beta-d-galactopyranoside Natural products OC1C(O)C(C(O)C)OC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OEKUVLQNKPXSOY-UHFFFAOYSA-N 0.000 description 1
- QPHXPNUXTNHJOF-UHFFFAOYSA-N quercetin-7-O-beta-L-rhamnopyranoside Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 QPHXPNUXTNHJOF-UHFFFAOYSA-N 0.000 description 1
- OXGUCUVFOIWWQJ-HQBVPOQASA-N quercitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-HQBVPOQASA-N 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 1
- 229960001755 resorcinol Drugs 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 235000019265 sodium DL-malate Nutrition 0.000 description 1
- 229960001790 sodium citrate Drugs 0.000 description 1
- 239000001394 sodium malate Substances 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 229940074404 sodium succinate Drugs 0.000 description 1
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- SFVFIFLLYFPGHH-UHFFFAOYSA-M stearalkonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 SFVFIFLLYFPGHH-UHFFFAOYSA-M 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- AGGIJOLULBJGTQ-UHFFFAOYSA-N sulfoacetic acid Chemical compound OC(=O)CS(O)(=O)=O AGGIJOLULBJGTQ-UHFFFAOYSA-N 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical class NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- WEAPVABOECTMGR-UHFFFAOYSA-N triethyl 2-acetyloxypropane-1,2,3-tricarboxylate Chemical compound CCOC(=O)CC(C(=O)OCC)(OC(C)=O)CC(=O)OCC WEAPVABOECTMGR-UHFFFAOYSA-N 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- SZEMGTQCPRNXEG-UHFFFAOYSA-M trimethyl(octadecyl)azanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C SZEMGTQCPRNXEG-UHFFFAOYSA-M 0.000 description 1
- 229940118594 trimethylolpropane triisostearate Drugs 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- APVVRLGIFCYZHJ-UHFFFAOYSA-N trioctyl 2-hydroxypropane-1,2,3-tricarboxylate Chemical compound CCCCCCCCOC(=O)CC(O)(C(=O)OCCCCCCCC)CC(=O)OCCCCCCCC APVVRLGIFCYZHJ-UHFFFAOYSA-N 0.000 description 1
- 239000003656 tris buffered saline Substances 0.000 description 1
- COXJMKGEQAWXNP-UHFFFAOYSA-N tris(14-methylpentadecyl) 2-hydroxypropane-1,2,3-tricarboxylate Chemical compound CC(C)CCCCCCCCCCCCCOC(=O)CC(O)(C(=O)OCCCCCCCCCCCCCC(C)C)CC(=O)OCCCCCCCCCCCCCC(C)C COXJMKGEQAWXNP-UHFFFAOYSA-N 0.000 description 1
- RHNXTZDKMRCKKT-UHFFFAOYSA-N tris(6-methylheptyl) 2-hydroxypropane-1,2,3-tricarboxylate Chemical compound CC(C)CCCCCOC(=O)CC(O)(C(=O)OCCCCCC(C)C)CC(=O)OCCCCCC(C)C RHNXTZDKMRCKKT-UHFFFAOYSA-N 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 235000013799 ultramarine blue Nutrition 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 238000003026 viability measurement method Methods 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000008979 vitamin B4 Nutrition 0.000 description 1
- 239000011579 vitamin B4 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9755—Gymnosperms [Coniferophyta]
- A61K8/9761—Cupressaceae [Cypress family], e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Botany (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
본 발명은 잣나무 목재와 케나프(양마) 혼합 추출물을 포함하는 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition comprising a mixed extract of pine nut wood and kenaf (yangma).
잣나무는 구과목 소나무과의 식물로, 학명은 Pinus koraiensis이다. 나무를 베면 심재가 붉은 색이어서 홍송(紅松)이라 부르며, 한자명은 백자목(柏子木) 혹은 오엽송(五葉松)이라 부른다. 한반도와 중국 동북부, 극동러시아, 일본 혼슈와 시코쿠에 분포하며, 한국에서는 대부분 고산지대에서 자생하고 있다. 우리나라의 경우 전국적으로 23 만 ha의 잣나무가 식재되어 있으며, 이는 우리나라의 주요 산림소득자원 중 하나이다.Pine tree is a plant of the coniferous pine family, and its scientific name is Pinus koraiensis . When the tree is cut down, the heartwood is red, so it is called Hongsong (紅松). It is distributed in the Korean Peninsula, Northeast China, Far East Russia, Japan Honshu and Shikoku, and in Korea, it grows wild in most alpine areas. In Korea, 230,000 ha of pine nuts are planted nationwide, which is one of the country's major forest income resources.
그러나 유사 수종인 소나무가 화장품 재료나 기능성 식품 등의 다양한 분야에서 활용되고 있는 것과 달리, 잣나무의 경우 현재 식용으로 잣 열매(백잣)와 임업용으로 목재만이 주로 사용되고 있어 활용도가 높지 않은 실정이다.However, unlike pine trees, which are similar species, and are used in various fields such as cosmetic materials and functional foods, pine nuts are currently used mainly for food and wood for forestry, so their utilization is not high.
특히, 소나무는 벌채나 간벌목이 많지 않아 재료의 수급이 어려운 반면, 잣나무는 다량의 벌채 또는 간벌목을 통하여 손쉽게 재료를 수급할 수 있는 장점을 갖고 있으므로, 이를 이용한 신소득 창출 응용제품 개발이 신속히 이루어질 필요가 있다.In particular, it is difficult to supply and demand materials for pine trees because there are not many felling or thinning, whereas pine trees have the advantage of being able to easily supply materials through large amounts of felling or thinning. There is a need.
한편, 케나프는 쌍떡잎식물 아욱목 아욱과(Malvaceae)의 한해살이 또는 두해살이풀로 학명은 Hibiscus cannabinus이다. 우리나라에서는 '양마'라고도 하며, 아프리카와 인도가 원산지이다. 줄기는 곧게 서고 높이는 1.5 ~ 5 미터이며 줄기 두께는 1 ~ 2 센티미터이다. 잎은 어긋나고 손바닥 모양으로 깊게 갈라지며 긴 잎자루가 있다. 당초 우리나라에 케나프를 도입한 이유는 이 잎을 소 등의 가축에 먹이는 조사료로 활용하기 위함이었다. 꽃은 여름에 피고 잎겨드랑이에 무궁화와 유사한 꽃이 2 ∼ 3 개씩 모여 달린다. 꽃의 지름은 10 cm이고, 노란빛이 도는 흰색이며 가운데 부분은 검붉은 빛을 띤다. 꽃받침은 5 개로 갈라지고끝이 뾰족하며 표면에 많은 돌기가 있다. 꽃잎은 5 개이고, 수술은 통처럼 모여달린다. 꽃은 히비스커스(Hibiscus)의 한 종류로서 식용이 가능할 것으로 추정된다. 열매는 협과이고 길이 1 cm의 긴 달걀 모양이며 5실으로 나뉘고 1실에 3 ∼ 5 개의 종자가 들어있다. 종자는 잿빛이 도는 갈색이고 20 %의 지방이 들어 있다. 이 지방을 정제하여 식용이나 공업용 유지로 사용한다. On the other hand, kenaf is an annual or biennial plant of the dicotyledonous malvaceae family (Malvaceae), and its scientific name is Hibiscus cannabinus . It is also called 'yangma' in Korea, and is native to Africa and India. The stem is erect, 1.5 to 5 meters high, and the stem is 1 to 2 centimeters thick. Leaves are alternate, palm-shaped, deeply split, and have long petioles. Initially, the reason for introducing kenaf to Korea was to use this leaf as a forage for livestock such as cattle. Flowers bloom in summer, and 2 or 3 flowers similar to Mugunghwa hang in the axils of the leaves. Flowers are 10 cm in diameter, yellowish white, and dark red in the middle. The calyx is divided into 5 pieces, the tip is sharp, and there are many projections on the surface. There are 5 petals, and the stamens run together like a barrel. The flower is a type of hibiscus and is presumed to be edible. The fruits are legumes, 1 cm long, egg-shaped, divided into 5 rooms, and each room contains 3 to 5 seeds. Seeds are grayish-brown and contain 20% fat. This fat is refined and used as edible or industrial oil.
케나프를 수확한 후 발효시켜 얻은 길이 22 cm 정도의 섬유는 삼이나 황마의 대용품으로 사용할 수 있으나, 이 섬유는 황마 섬유보다 질기고 다소 거칠며 유연성이 떨어질 뿐만아니라 섬유 생산의 경제성이 떨어지기 때문에 국내에서는 생산이 되지 않고 있다. Fiber with a length of about 22 cm obtained by fermenting kenaf after harvesting can be used as a substitute for hemp or jute. is not being produced.
즉, 케나프의 잎은 조사료로 활용되기 위하여 시도되고 있으나, 케나프 지상부의 대부분을 차지하는 줄기 부분은 바이오플라스틱에 혼합재로 사용하는 것이 시도된 적이 있을 뿐 실제 상용되는 활용처가 없는 실정이며, 특히 화장품 분야에서는 사용된 적이 없다.That is, kenaf leaves have been tried to be used as forage, but the stem part, which occupies most of the aerial part of kenaf, has only been tried to be used as a mixture for bioplastics, but there is no actual commercial use, especially in cosmetics. never used in the field.
전술한 배경기술은 발명자가 본원의 개시 내용을 도출하는 과정에서 보유하거나 습득한 것으로서, 반드시 본 출원 전에 일반 공중에 공개된 공지기술이라고 할 수는 없다.The above background art is possessed or acquired by the inventor in the process of deriving the disclosure of the present application, and cannot necessarily be said to be known art disclosed to the general public prior to the present application.
본 발명은 상술한 문제점을 해결하기 위한 것으로, 본 발명의 목적은, 잣나무 목재와 케나프 혼합 추출물을 이용한 기능성 화장료 조성물을 제공하는 것이다.The present invention is to solve the above problems, and an object of the present invention is to provide a functional cosmetic composition using a mixed extract of pine nut wood and kenaf.
그러나, 본 발명이 해결하고자 하는 과제는 이상에서 언급한 것들로 제한되지 않으며, 언급되지 않은 또 다른 과제들은 아래의 기재로부터 해당 분야 통상의 기술자에게 명확하게 이해될 수 있을 것이다.However, the problem to be solved by the present invention is not limited to those mentioned above, and other problems not mentioned will be clearly understood by those skilled in the art from the description below.
본 발명의 일 측면은, 잣나무(Pinus koraiensis) 목재 추출물 및 케나프(Hibiscus cannabinus) 추출물의 혼합물을 유효성분으로 포함하는, 화장료 조성물을 제공한다.One aspect of the present invention provides a cosmetic composition comprising a mixture of a pine tree ( Pinus koraiensis ) wood extract and a kenaf ( Hibiscus cannabinus ) extract as an active ingredient.
일 실시형태에 따르면, 상기 잣나무 목재 추출물 및 상기 케나프 추출물의 중량비는, 1 : 10 내지 10 : 1인 것일 수 있다.According to one embodiment, the weight ratio of the pine wood extract and the kenaf extract may be 1:10 to 10:1.
일 실시형태에 따르면, 상기 혼합물은, 상기 화장료 조성물 전체 중, 0.1 중량% 내지 50 중량%로 포함되는 것일 수 있다.According to one embodiment, the mixture may be included in an amount of 0.1% to 50% by weight, based on the total amount of the cosmetic composition.
일 실시형태에 따르면, 상기 추출물은, 물, 탄소수 1 내지 4의 저급 알코올, 아세톤, 에틸아세테이트, 클로로포름, 1,3-부틸렌글리콜, n-헥산, 디에틸에테르, 부틸아세테이트 및 디클로로메탄으로 이루어진 군에서 선택되는 하나 이상을 추출 용매로 하여 추출된 것일 수 있다.According to one embodiment, the extract is composed of water, lower alcohol having 1 to 4 carbon atoms, acetone, ethyl acetate, chloroform, 1,3-butylene glycol, n-hexane, diethyl ether, butyl acetate and dichloromethane It may be extracted by using at least one selected from the group as an extraction solvent.
일 실시형태에 따르면, 상기 추출은, 1 ℃ 내지 40 ℃의 온도에서 4 시간 내지 60 시간 동안 수행되는 것일 수 있다.According to one embodiment, the extraction may be performed at a temperature of 1 °C to 40 °C for 4 hours to 60 hours.
일 실시형태에 따르면, 상기 화장료 조성물은, 1,1 -디페닐-2-피크릴하이드라질(1,1 -diphenyl-2-picrylhydrazyl, DPPH) 라디칼 소거능, 2,2'-아지노비스-(3-에틸벤조티아졸린-6-설폰산)(2,2'-Azinobis-(3-ethylbenzothiazoline-6-sulfonic acid, ABTS) 라디칼 소거능 또는 SOD(superoxide dismutase) 유사활성을 갖는 것일 수 있다.According to one embodiment, the cosmetic composition contains 1,1-diphenyl-2-picrylhydrazyl (1,1-diphenyl-2-picrylhydrazyl, DPPH) radical scavenging activity, 2,2'-azinobis-(3 -Ethylbenzothiazoline-6-sulfonic acid) (2,2'-Azinobis-(3-ethylbenzothiazoline-6-sulfonic acid, ABTS) may have radical scavenging activity or SOD (superoxide dismutase)-like activity.
일 실시형태에 따르면, 상기 화장료 조성물은, MITF(microphthalmia associated transcription factor) 발현 억제, TRP-1(tyrosinase related protein-1) 발현 억제, TRP-2(tyrosinase related protein-2) 발현 억제, 티로시나아제(Tyrosinase) 활성 저해 및 엘라스타제(elastase) 활성 저해 중 적어도 하나 이상의 성능을 갖는 것일 수 있다.According to one embodiment, the cosmetic composition inhibits MITF (microphthalmia associated transcription factor) expression, TRP-1 (tyrosinase related protein-1) expression, TRP-2 (tyrosinase related protein-2) expression inhibition, tyrosinase (Tyrosinase) activity inhibition and elastase (elastase) activity may have at least one or more performance.
일 실시형태에 따르면, 상기 화장료 조성물은, 잣나무(Pinus koraiensis) 잎 에탄올 추출물을 유효성분으로 더 포함하는 것일 수 있다.According to one embodiment, the cosmetic composition, pine nut ( Pinus koraiensis ) It may be to further include a leaf ethanol extract as an active ingredient.
일 실시형태에 따르면, 상기 혼합물 100 중량부에 대하여, 상기 잣나무 잎 에탄올 추출물은 10 중량부 내지 100 중량부로 포함되는 것일 수 있다.According to one embodiment, with respect to 100 parts by weight of the mixture, the pine nut leaf ethanol extract may be included in 10 parts by weight to 100 parts by weight.
일 실시형태에 따르면, 상기 화장료 조성물은, 병풀 추출물, 프로폴리스 추출물, 어성초 추출물, 녹차잎 추출물, 맥문동 추출물 및 구기자 추출물로 이루어진 군에서 선택되는 하나 이상의 식물성 추출물을 유효 성분으로 더 포함하는 것일 수 있다.According to one embodiment, the cosmetic composition may further include, as an active ingredient, one or more vegetable extracts selected from the group consisting of centella asiatica extract, propolis extract, houttuynia cordata extract, green tea leaf extract, walnut extract, and wolfberry extract. .
일 실시형태에 따르면, 상기 혼합물 100 중량부에 대하여, 상기 식물성 추출물은 1 중량부 내지 30 중량부로 포함되는 것일 수 있다.According to one embodiment, based on 100 parts by weight of the mixture, the vegetable extract may be included in 1 part by weight to 30 parts by weight.
일 실시형태에 따르면, 상기 화장료 조성물은, 항산화용, 미백용, 주름개선용, 수렴용, 모공수축용 또는 염증 억제용인 것일 수 있다.According to one embodiment, the cosmetic composition may be for antioxidant, whitening, wrinkle improvement, convergence, pore contraction, or inflammation inhibition.
일 실시형태에 따르면, 상기 화장료는, 화장수, 토너, 스킨, 로션, 에멀젼, 크림, 에센스, 세럼, 젤 및 팩으로 이루어지는 군으로부터 선택되는 어느 하나인 기초 화장료, 립스틱, 틴트, 립글로우, 립밤, 비비크림, 파운데이션, 파우더, 마스카라, 아이쉐도우 및 아이라이너로부터 선택되는 메이크업 화장료, 피부각질 스크럽, 클렌징워터, 클렌징오일, 클렌징크림 및 폼클렌징으로 이루어지는 군으로부터 선택되는 어느 하나인 세정용 화장료, 샴푸, 린스 및 트리트먼트로 이루어지는 군으로부터 선택되는 어느 하나인 모발용 화장료, 및 바디스크럽, 바디로션, 바디크림, 및 바디워시로 이루어지는 군으로부터 선택되는 어느 하나인 바디용 화장료,로 이루어지는 군으로부터 선택되는 하나 이상을 포함하는 것일 수 있다.According to one embodiment, the cosmetic is any one of basic cosmetics selected from the group consisting of lotion, toner, skin, lotion, emulsion, cream, essence, serum, gel, and pack, lipstick, tint, lip glow, lip balm, Cosmetics for washing, shampoo, At least one selected from the group consisting of cosmetics for hair, which is any one selected from the group consisting of rinse and treatment, and cosmetics for body, which is any one selected from the group consisting of body scrub, body lotion, body cream, and body wash It may contain.
본 발명에 따른 화장료 조성물은, 잣나무 목재 추출물 및 케나프 추출물의 혼합물을 함유함으로써, 항산화, 미백 및 주름 개선 성능을 나타내는 효과가 있다.The cosmetic composition according to the present invention, by containing a mixture of pine wood extract and kenaf extract, has the effect of exhibiting antioxidant, whitening and wrinkle improvement performance.
특히, 잣나무 목제 추출물 및 케나프 추출물을 동시 혼합함으로써, 잣나무 목재 추출물 또는 케나프 추출물을 별도로 함유한 것과 비교하여 더 뛰어난 성능을 나타내는 효과를 갖는다.In particular, by simultaneously mixing the pine nut wood extract and the kenaf extract, it has an effect of exhibiting superior performance compared to the case where the pine wood extract or the kenaf extract is separately contained.
또한, 잣나무 잎 추출물 또는 식물성 추출물을 일정 성분비로 포함함으로써, 주름 개선 및 염증 억제 성능을 향상시킬 수 있는 효과가 있다.In addition, by including the pine nut leaf extract or vegetable extract at a certain component ratio, there is an effect of improving wrinkle improvement and anti-inflammatory performance.
나아가, 현재 공산품 재료로 활용되지 못하는 산림자원인 잣나무와 농산물인 케나프를 활용한 신제품 개발로 농·임업인과 지역 기업의 신소득 창출에 기여할 수 있다.Furthermore, by developing new products using pine nut, a forest resource that is currently not used as a material for industrial products, and kenaf, an agricultural product, it can contribute to the creation of new income for farmers, forestry workers and local companies.
도 1은, 잣나무 목재 추출물, 케나프 추출물 및 이들의 혼합물 전자공여능 측정 결과이다.
도 2는, 잣나무 목재 추출물, 케나프 추출물 및 이들의 혼합물 ABTS radical 소거능 측정 결과이다.
도 3은, 잣나무 목재 추출물, 케나프 추출물 및 이들의 혼합물 SOD 유사활성 측정 결과이다.
도 4는, 잣나무 목재 추출물, 케나프 추출물 및 이들의 혼합물의 Tyrosinase 저해율 측정 결과이다.
도 5는, 잣나무 목재 추출물, 케나프 추출물 및 이들의 혼합물의 Elastase 저해율 측정 결과이다.
도 6은, 잣나무 목재 추출물, 케나프 추출물 및 이들의 혼합물의 피부수렴 활성 측정 결과이다.
도 7은, 멜라노마 세포(B16F10)에서의 잣나무 목재 추출물 및 케나프 지상부 추출물 혼합물의 농도별 세포 생존율을 나타낸 것이다.
도 8은, 멜라노마 세포(B16F10)에서의 잣나무 목재 추출물 및 케나프 지상부 추출물 혼합물의 농도별 MITF, tyrosinase, TRP-1 및 TRP-2 단백질 발현량을 나타낸 것이다.
도 9는, 멜라노마 세포(B16F10)에서의 잣나무 목재 추출물 및 케나프 지상부 추출물 혼합물의 농도별 MITF, TRP-1, TRP-2 및 tyrosinase mRNA 발현량을 나타낸 것이다.1 is a result of measuring the electron donating ability of a cypress wood extract, a kenaf extract, and a mixture thereof.
2 is a result of measuring the ABTS radical scavenging activity of a pine nut extract, a kenaf extract, and a mixture thereof.
3 is a result of measuring SOD-like activities of pine nut extract, kenaf extract, and mixtures thereof.
4 is a result of measuring Tyrosinase inhibition rate of pine wood extract, kenaf extract, and mixtures thereof.
5 is a result of measuring the Elastase inhibition rate of pine wood extract, kenaf extract, and mixtures thereof.
6 is a result of measuring skin astringent activity of pine wood extract, kenaf extract, and mixtures thereof.
Figure 7 shows the cell viability of a mixture of pine wood extract and kenaf aerial part extract according to concentration in melanoma cells (B16F10).
Figure 8 shows the expression levels of MITF, tyrosinase, TRP-1 and TRP-2 proteins in melanoma cells (B16F10) by concentrations of a mixture of pine wood extract and kenaf aerial part extract.
9 shows the expression levels of MITF, TRP-1, TRP-2, and tyrosinase mRNA in melanoma cells (B16F10) by concentrations of a mixture of pine wood extract and kenaf aerial part extract.
이하에서, 첨부된 도면을 참조하여 실시예들을 상세하게 설명한다. 그러나, 실시예들에는 다양한 변경이 가해질 수 있어서 특허출원의 권리 범위가 이러한 실시예들에 의해 제한되거나 한정되는 것은 아니다. 실시예들에 대한 모든 변경, 균등물 내지 대체물이 권리 범위에 포함되는 것으로 이해되어야 한다.Hereinafter, embodiments will be described in detail with reference to the accompanying drawings. However, since various changes can be made to the embodiments, the scope of the patent application is not limited or limited by these embodiments. It should be understood that all changes, equivalents or substitutes to the embodiments are included within the scope of rights.
실시예에서 사용한 용어는 단지 설명을 목적으로 사용된 것으로, 한정하려는 의도로 해석되어서는 안된다. 단수의 표현은 문맥상 명백하게 다르게 뜻하지 않는 한, 복수의 표현을 포함한다. 본 명세서에서, "포함하다" 또는 "가지다" 등의 용어는 명세서 상에 기재된 특징, 숫자, 단계, 동작, 구성요소, 부품 또는 이들을 조합한 것이 존재함을 지정하려는 것이지, 하나 또는 그 이상의 다른 특징들이나 숫자, 단계, 동작, 구성요소, 부품 또는 이들을 조합한 것들의 존재 또는 부가 가능성을 미리 배제하지 않는 것으로 이해되어야 한다.Terms used in the examples are used only for descriptive purposes and should not be construed as limiting. Singular expressions include plural expressions unless the context clearly dictates otherwise. In this specification, terms such as "include" or "have" are intended to designate that there is a feature, number, step, operation, component, part, or combination thereof described in the specification, but one or more other features It should be understood that the presence or addition of numbers, steps, operations, components, parts, or combinations thereof is not precluded.
다르게 정의되지 않는 한, 기술적이거나 과학적인 용어를 포함해서 여기서 사용되는 모든 용어들은 실시예가 속하는 기술 분야에서 통상의 지식을 가진 자에 의해 일반적으로 이해되는 것과 동일한 의미를 가지고 있다. 일반적으로 사용되는 사전에 정의되어 있는 것과 같은 용어들은 관련 기술의 문맥 상 가지는 의미와 일치하는 의미를 가지는 것으로 해석되어야 하며, 본 출원에서 명백하게 정의하지 않는 한, 이상적이거나 과도하게 형식적인 의미로 해석되지 않는다.Unless defined otherwise, all terms used herein, including technical or scientific terms, have the same meaning as commonly understood by a person of ordinary skill in the art to which the embodiment belongs. Terms such as those defined in commonly used dictionaries should be interpreted as having a meaning consistent with the meaning in the context of the related art, and unless explicitly defined in the present application, they should not be interpreted in an ideal or excessively formal meaning. don't
또한, 첨부 도면을 참조하여 설명함에 있어, 도면 부호에 관계없이 동일한 구성 요소는 동일한 참조부호를 부여하고 이에 대한 중복되는 설명은 생략하기로 한다. 실시예를 설명함에 있어서 관련된 공지 기술에 대한 구체적인 설명이 실시예의 요지를 불필요하게 흐릴 수 있다고 판단되는 경우 그 상세한 설명을 생략한다.In addition, in the description with reference to the accompanying drawings, the same reference numerals are given to the same components regardless of reference numerals, and overlapping descriptions thereof will be omitted. In describing the embodiment, if it is determined that a detailed description of a related known technology may unnecessarily obscure the gist of the embodiment, the detailed description will be omitted.
또한, 실시 예의 구성 요소를 설명하는 데 있어서, 제 1, 제 2, A, B, (a), (b) 등의 용어를 사용할 수 있다. 이러한 용어는 그 구성 요소를 다른 구성 요소와 구별하기 위한 것일 뿐, 그 용어에 의해 해당 구성 요소의 본질이나 차례 또는 순서 등이 한정되지 않는다. 어떤 구성 요소가 다른 구성요소에 "연결", "결합" 또는 "접속"된다고 기재된 경우, 그 구성 요소는 그 다른 구성요소에 직접적으로 연결되거나 접속될 수 있지만, 각 구성 요소 사이에 또 다른 구성 요소가 "연결", "결합" 또는 "접속"될 수도 있다고 이해되어야 할 것이다.In addition, in describing the components of the embodiment, terms such as first, second, A, B, (a), and (b) may be used. These terms are only used to distinguish the component from other components, and the nature, order, or order of the corresponding component is not limited by the term. When an element is described as being “connected,” “coupled to,” or “connected” to another element, that element may be directly connected or connected to the other element, but there may be another element between the elements. It should be understood that may be "connected", "coupled" or "connected".
어느 하나의 실시 예에 포함된 구성요소와, 공통적인 기능을 포함하는 구성요소는, 다른 실시 예에서 동일한 명칭을 사용하여 설명하기로 한다. 반대되는 기재가 없는 이상, 어느 하나의 실시 예에 기재한 설명은 다른 실시 예에도 적용될 수 있으며, 중복되는 범위에서 구체적인 설명은 생략하기로 한다.Components included in one embodiment and components having common functions will be described using the same names in other embodiments. Unless stated to the contrary, descriptions described in one embodiment may be applied to other embodiments, and detailed descriptions will be omitted to the extent of overlap.
본 발명의 일 측면은, 잣나무(Pinus koraiensis) 목재 추출물 및 케나프(Hibiscus cannabinus) 추출물의 혼합물을 유효성분으로 포함하는, 화장료 조성물을 제공한다.One aspect of the present invention provides a cosmetic composition comprising a mixture of a pine tree ( Pinus koraiensis ) wood extract and a kenaf ( Hibiscus cannabinus ) extract as an active ingredient.
본 발명에 따른 화장료 조성물은, 잣나무 목재 추출물 및 케나프 추출물의 혼합물을 함유함으로써, 항산화, 미백 및 주름 개선 효과를 갖는 특징이 있다.The cosmetic composition according to the present invention, by containing a mixture of pine wood extract and kenaf extract, has antioxidant, whitening and anti-wrinkle effects.
특히, 잣나무 목제 추출물 및 케나프 추출물을 동시 혼합함으로써, 잣나무 목재 추출물 또는 케나프 추출물을 별도로 함유한 것과 비교하여 더 뛰어난 성능을 나타내는 효과를 갖는다.In particular, by simultaneously mixing the pine nut wood extract and the kenaf extract, it has an effect of exhibiting superior performance compared to the case where the pine wood extract or the kenaf extract is separately contained.
본 발명에 있어서, 상기 잣나무 목재 추출물 및 상기 케나프 추출물은, 잣나무 목재 또는 케나프의 추출물, 이의 분획물 또는 상기 분획물로부터 분리한 활성 분획을 모두 포함하는 개념이다.In the present invention, the pine nut wood extract and the kenaf extract include both extracts of pine nut wood or kenaf, fractions thereof, or active fractions separated from the fractions.
상기 잣나무 목재는, 잣나무의 목부로 나이테가 뚜렷하고 심재는 황홍색, 변재는 담홍황백색으로 심재와 변재의 구분이 뚜렷한 특징이 있다.The pine tree wood is characterized by clear growth rings as the neck of the pine tree, heartwood is yellowish red, and sapwood is pale reddish yellowish white, so that the heartwood and sapwood are clearly distinguished.
잣나무 목재에는, 피니톨, 피노실빈, 크리신, 피노반크신 및 피노셈브린 성분이 포함되어 있다.Pinitol, pinosylbin, chrysin, pinobaxin and pinocembrin are contained in pine wood.
피니톨은 혈당 조절 역할을 수행하는 카이로이노시톨(Chiro-inositol)을 보충해 인슐린 저항성을 개선하는데 도움을 주는 물질로 알려져 있으며, 노화억제에도 도움을 준다.Pinitol is known as a substance that helps improve insulin resistance by supplementing chiro-inositol, which plays a role in blood sugar control, and also helps suppress aging.
피노실빈(Pinosylvin)은 염증 유도 시그널인 NF-kB 활성화를 차단해 다양한 염증 유도 매개체들의 생산을 억제하며, 아토피, 건선, 여드름 등과 같은 염증성 질환에 유용하게 이용될 수 있는 물질이다.Pinosylvin inhibits the production of various inflammation-inducing mediators by blocking the activation of NF-kB, an inflammation-inducing signal, and is a substance that can be usefully used in inflammatory diseases such as atopy, psoriasis, and acne.
크리신(Chrysin)은 테스토스테론이 에스트로젠으로 변하는 것을 막아주는 역할을 수행한다. 또한, 피노반크신(pinobanksin) 및 피노셈브린(pinocembrin)은 항진균 효능을 나타내는 성분으로 알려져 있다.Chrysin blocks the conversion of testosterone to estrogen. In addition, pinobanksin and pinocembrin are known as components exhibiting antifungal efficacy.
본 발명에 따른 화장료 조성물은, 잣나무 목재 내 포함된 피니톨, 피노실빈, 크리신, 피노반크신 및 피노셈브린 성분들이 유효하게 추출된 잣나무 목재 추출물을 포함으로써, 항노화 및 항염증 효능을 나타낼 수 있다.The cosmetic composition according to the present invention may exhibit anti-aging and anti-inflammatory effects by including a pine wood extract in which pinitol, pinosylbin, chrysin, pinovaxin and pinocembrin components contained in pine wood are effectively extracted. there is.
일 실시형태에 따르면, 상기 잣나무 목재 추출물 및 상기 케나프 추출물의 중량비는, 1 : 10 내지 10 : 1인 것일 수 있다.According to one embodiment, the weight ratio of the pine wood extract and the kenaf extract may be 1:10 to 10:1.
바람직하게는, 상기 중량비는 1 : 5 내지 5 : 1인 것일 수 있고, 더욱 바람직하게는, 1 : 3 내지 3 : 1인 것일 수 있고, 더욱 더 바람직하게는, 1 : 2 내자 2 : 1인 것일 수 있다.Preferably, the weight ratio may be 1:5 to 5:1, more preferably, 1:3 to 3:1, and even more preferably, 1:2 to 2:1 it could be
상기 중량비 범위는, 상기 잣나무 목재 추출물 및 상기 케나프 추출물이 가진 기능을 최대화할 수 있는 범위이며, 단일 추출물과 비교하여 효능을 가장 극대화할 수 있는 범위이다.The weight ratio range is a range that can maximize the functions of the pine wood extract and the kenaf extract, and is a range that can maximize the efficacy compared to a single extract.
일 실시형태에 따르면, 상기 혼합물은, 상기 화장료 조성물 전체 중, 0.1 중량% 내지 50 중량%로 포함되는 것일 수 있다.According to one embodiment, the mixture may be included in an amount of 0.1% to 50% by weight, based on the total amount of the cosmetic composition.
바람직하게는, 상기 화장료 조성물 전체 중, 0.3 중량% 내지 30 중량%로 포함될 수 있고, 더욱 바람직하게는, 0.5 중량% 내지 20 중량%로 포함될 수 있으며, 더욱 더 바람직하게는, 1 중량% 내지 10 중량%로 포함될 수 있다.Preferably, of the total cosmetic composition, it may be included in 0.3% to 30% by weight, more preferably, it may be included in 0.5% to 20% by weight, and even more preferably, 1% to 10% by weight may be included in weight percent.
상기 혼합물의 함량이 상기 범위 미만일 경우, 항산화, 미백, 주름개선, 수렴, 모공 수축 및 염증 억제와 같은 효능이 미미하게 나타날 수 있다.When the content of the mixture is less than the above range, effects such as antioxidant, whitening, wrinkle improvement, convergence, pore contraction, and inflammation inhibition may be insignificant.
반면, 상기 범위를 초과할 경우, 제형 안정성이 저하되거나 피부 자극성이 증가할 수 있으며, 비경제적일 수 있다.On the other hand, when the above range is exceeded, formulation stability may be reduced or skin irritation may be increased, and may be uneconomical.
일 실시형태에 따르면, 상기 추출물은, 물, 탄소수 1 내지 4의 저급 알코올, 아세톤, 에틸아세테이트, 클로로포름, 1,3-부틸렌글리콜, n-헥산, 디에틸에테르, 부틸아세테이트 및 디클로로메탄으로 이루어진 군에서 선택되는 하나 이상을 추출 용매로 하여 추출된 것일 수 있다.According to one embodiment, the extract is composed of water, lower alcohol having 1 to 4 carbon atoms, acetone, ethyl acetate, chloroform, 1,3-butylene glycol, n-hexane, diethyl ether, butyl acetate and dichloromethane It may be extracted by using at least one selected from the group as an extraction solvent.
바람직하게는, 상기 추출물은, 탄소수 1 내지 4의 저급 알코올 추출물일 수 있고, 더욱 바람직하게는, 에탄올 추출물일 수 있다.Preferably, the extract may be a lower alcohol extract having 1 to 4 carbon atoms, and more preferably, an ethanol extract.
상기 추출 용매로서 에탄올은, 50 %(v/v) 내지 90 %(v/v) 에탄올을 사용할 수 있고, 바람직하게는, 60 %(v/v) 내지 80 %(v/v)에탄올을 사용할 수 있다.Ethanol as the extraction solvent may use 50% (v/v) to 90% (v/v) ethanol, preferably 60% (v/v) to 80% (v/v) ethanol. can
상기 에탄올의 농도 범위는, 상기 잣나무 목재 추출물 및 상기 케나프 추출물의 에탄올 내 유효성분의 추출 효율을 최대화할 수 있는 범위일 수 있다.The concentration range of the ethanol may be within a range capable of maximizing the extraction efficiency of the active ingredient in the ethanol of the pine wood extract and the kenaf extract.
일 실시형태에 따르면, 상기 추출은, 1 ℃ 내지 40 ℃의 온도에서 4 시간 내지 60 시간 동안 수행되는 것일 수 있다. 바람직하게는, 20 ℃ 내지 30 ℃의 온도에서 24 시간 내지 48 시간 동안 수행되는 것일 수 있다.According to one embodiment, the extraction may be performed at a temperature of 1 °C to 40 °C for 4 hours to 60 hours. Preferably, it may be carried out for 24 hours to 48 hours at a temperature of 20 ℃ to 30 ℃.
상기 온도 및 시간 범위를 벗어날 경우, 상기 추출물 내 유효성분이 충분히 추출되지 않거나, 유효성분이 파괴될 수 있다.If the temperature and time are out of range, the active ingredient in the extract may not be sufficiently extracted or the active ingredient may be destroyed.
일 실시형태에 따르면, 상기 추출은 1 회 내지 5 회 수행될 수 있다. 이는, 상기 추출물 내 유효성분의 추출이 충분히 이루어지게 하기 위함이다.According to one embodiment, the extraction may be performed 1 to 5 times. This is to ensure sufficient extraction of the active ingredient in the extract.
상기 추출물은, 여과, 농축 및 동결 건조의 공정이 추가적으로 수행되어 파우더 형태로 제조될 수 있다.The extract may be prepared in a powder form by additionally performing filtration, concentration, and freeze-drying processes.
일 실시형태에 따르면, 상기 화장료 조성물은, 1,1 -디페닐-2-피크릴하이드라질(1,1 -diphenyl-2-picrylhydrazyl, DPPH) 라디칼 소거능, 2,2'-아지노비스-(3-에틸벤조티아졸린-6-설폰산)(2,2'-Azinobis-(3-ethylbenzothiazoline-6-sulfonic acid, ABTS) 라디칼 소거능 또는 SOD(superoxide dismutase) 유사활성을 갖는 것일 수 있다.According to one embodiment, the cosmetic composition contains 1,1-diphenyl-2-picrylhydrazyl (1,1-diphenyl-2-picrylhydrazyl, DPPH) radical scavenging activity, 2,2'-azinobis-(3 -Ethylbenzothiazoline-6-sulfonic acid) (2,2'-Azinobis-(3-ethylbenzothiazoline-6-sulfonic acid, ABTS) may have radical scavenging activity or SOD (superoxide dismutase)-like activity.
일 실시형태에 따르면, 상기 화장료 조성물은, MITF(microphthalmia associated transcription factor) 발현 억제, TRP-1(tyrosinase related protein-1) 발현 억제, TRP-2(tyrosinase related protein-2) 발현 억제, 티로시나아제(Tyrosinase) 활성 저해 및 엘라스타제(elastase) 활성 저해 중 적어도 하나 이상의 성능을 갖는 것일 수 있다.According to one embodiment, the cosmetic composition inhibits MITF (microphthalmia associated transcription factor) expression, TRP-1 (tyrosinase related protein-1) expression, TRP-2 (tyrosinase related protein-2) expression inhibition, tyrosinase (Tyrosinase) activity inhibition and elastase (elastase) activity may have at least one or more performance.
일반적으로, 멜라닌(melanin)은 자외선과 같은 외부 자극 요인으로부터 피부를 보호하기 위해 만들어진다. 피부에 멜라닌 색소가 과다 침착되면 원하지 않는 주근깨, 노인성 반점, 간반, 기미, 갈색 또는 흑점, 일광 색소반, 찰상 및 화상을 비롯한 상처 또는 피부염으로 인한 염증 후 과색소침착, 광독성 반응 또는 다른 유사한 소형의 고정 색소성 병변을 일으킬 수 있다.In general, melanin is produced to protect the skin from external stimuli such as ultraviolet rays. Excessive deposition of melanin in the skin can result in unwanted freckles, senile spots, liver spots, melasma, brown or sunspots, solar pigment spots, wounds including scratches and burns, or post-inflammatory hyperpigmentation due to dermatitis, phototoxic reactions, or other similar small It can cause fixed pigmented lesions.
멜라닌 생성은 티로시나아제(tyrosinase), TRP-1(tyrosinase related protein-1), TRP-2의 세 효소에 의해 조절된다. Melanin의 생합성 기전은 출발 물질인 티로신이 rate-limiting enzyme인 티로시나아제(tyrosinase)에 의해 DOPA (3,4-dihydroxyphenylalanin)과 DOPA 퀴논으로 변형되고, DOPA 크롬을 거쳐 중간체인 5,6-dihydroxyindole-2-carboxylic acid로 산화되어 유멜라닌(eumelanin)을 생성하게 된다. 또한 자외선에 의해 피부의 케라티노사이트(keratinocyte)가 자극을 받으면 α-MSH (α-melanocyte sitmulating hormone), ACTH(adrenocorricotropic hormone) 등의 신호전달물질이 멜라노사이트(melanocyte)로 분비된다. 멜라노사이트의 MC1R(melanocortin type 1 receptor) 수용체에서는 이러한 자극을 받아들여 세포내 cAMP(cyclic adenosine monophosphate) 수준을 증가시키며, cAMP의 증가는 PKA(protein kinase A)의 활성화를 일으키고, 뒤이어 CREB(cAMP response element-binding protein)의 인산화를 증가시킨다. 인산화된 CREB는 멜라노사이트의 특정 전사인자인 MITF(microphthalmia associated transcrpition factor)의 MITF의 발현을 일으키게 된다. MITF의 발현은 결국 멜라닌 생성의 주요 효소인 티로시나아제, TRP-1, TRP-2의 프로모터와의 결합을 촉진해 멜라닌 생합성을 증가시킨다.Melanin production is regulated by three enzymes: tyrosinase, TRP-1 (tyrosinase related protein-1), and TRP-2. The biosynthetic mechanism of melanin is that tyrosine, the starting material, is transformed into DOPA (3,4-dihydroxyphenylalanin) and DOPA quinone by the rate-limiting enzyme tyrosinase, and the intermediate 5,6-dihydroxyindole- It is oxidized to 2-carboxylic acid to produce eumelanin. In addition, when keratinocytes of the skin are stimulated by ultraviolet rays, signal transmitters such as α-MSH (α-melanocyte sitmulating hormone) and ACTH (adrenocorricotropic hormone) are secreted into melanocytes. MC1R (
피부에 노출되는 자외선이 증가함에 따라 여러 단백질 분해효소 중에서 기질을 분해하는 MMPs(matrix metalloproteinase)는 피부 광노화 발생에 중요한 역할을 한다. 피부 진피 내 세포 외 기질단백질(extracellular matrix)은 피부의 구조와 탄력성을 유지하는데 중요한 역할을 하는데, 그 중 80 ∼ 85 %가 type Ⅰ procollagen으로 이루어져 있다. Type Ⅰ procollagen은 전구체인 procollagen 형태로 합성된 후 세포 밖으로 배출되어 아미노 말단과 카복실말단이 잘려나간 후 완성된 collagen을 만들게 된다. 피부 진피 내 세포 외 기질 단백질의 재구성에는 여러 생체 반응이 관하며, 이중 특히 MMPs가 기질 단백질들을 분해하는 중요한 역할을 하고 있으며 intestitial collagenase (MMP-1), 72kD gelatinase (MMP-2), 92kD gelatinase (MMP-9), neutrophil collagenase (MMP-8), collagenase (MMP-13) 등 26가지 이상의 MMPs가 이미 알려져 있다. 자외선에 노출된 피부에서는 MMPs의 발현이 증가되며, 증가된 MMPs가 피부를 구성하고 있는 collagen을 분해하여 기질 단백질의 결핍을 초래하게 됨으로써 피부노화와 주름의 발생이 일어난다.As UV rays exposed to the skin increase, matrix metalloproteinases (MMPs), which degrade substrates among various proteolytic enzymes, play an important role in the occurrence of skin photoaging. Extracellular matrix proteins in the skin dermis play an important role in maintaining the structure and elasticity of the skin, of which 80 to 85% is composed of type I procollagen. Type I procollagen is synthesized in the form of procollagen, which is a precursor, and then released out of the cell to make finished collagen after amino and carboxyl ends are cut off. Reconstitution of extracellular matrix proteins in the skin dermis involves several biological reactions, among which MMPs play an important role in degrading matrix proteins, and intestitial collagenase (MMP-1), 72kD gelatinase (MMP-2), and 92kD gelatinase ( MMP-9), neutrophil collagenase (MMP-8), collagenase (MMP-13), and more than 26 MMPs are already known. The expression of MMPs increases in the skin exposed to UV rays, and the increased MMPs degrade collagen constituting the skin, resulting in a deficiency of matrix protein, resulting in skin aging and wrinkles.
본 발명에 따른 화장료 조성물은, 1,1 -디페닐-2-피크릴하이드라질(1,1 -diphenyl-2-picrylhydrazyl, DPPH) 라디칼 저해, 2,2'-아지노비스-(3-에틸벤조티아졸린-6-설폰산)(2,2'-Azinobis-(3-ethylbenzothiazoline-6-sulfonic acid, ABTS) 라디칼 저해, 티오바르비튜릭산 반응성 물질(Thiobarbituric acid reactive substances, TBARs) 저해, 항산화 물질 보호 인자(Antioxidant protection factor, PF) 증가 활성을 가짐으로써, 항산화 효과를 나타낸다.The cosmetic composition according to the present invention is a 1,1-diphenyl-2-picrylhydrazyl (1,1-diphenyl-2-picrylhydrazyl, DPPH) radical inhibition, 2,2'-azinobis- (3-ethylbenzo Thiazoline-6-sulfonic acid) (2,2'-Azinobis-(3-ethylbenzothiazoline-6-sulfonic acid, ABTS) radical inhibition, Thiobarbituric acid reactive substances (TBARs) inhibition, antioxidant protection By having an antioxidant protection factor (PF) increasing activity, it shows an antioxidant effect.
일 실시형태에 따르면, 상기 화장료 조성물은, 잣나무(Pinus koraiensis) 잎 에탄올 추출물을 유효성분으로 더 포함하는 것일 수 있다.According to one embodiment, the cosmetic composition, pine nut ( Pinus koraiensis ) It may be to further include a leaf ethanol extract as an active ingredient.
상기 잣나무 잎 에탄올 추출물은, 에스테라제(esterase) 활성을 억제함으로써, 엘라스틴(elastin) 분자 형태를 유지시키고, Pro COL1A2를 활성화시키며, MMP-1(Matrix Metalloproteinase-1) 및 MMP-9(Matrix Metalloproteinase-9)의 발현을 억제함으로써, 주름 개선 효과를 향상시킬 수 있다.The pine nut leaf ethanol extract maintains the form of elastin molecules by inhibiting esterase activity, activates Pro COL1A2, MMP-1 (Matrix Metalloproteinase-1) and MMP-9 (Matrix Metalloproteinase By suppressing the expression of -9), the anti-wrinkle effect can be improved.
또한, 폴리페놀계의 풍부한 생리활성 물질을 함유함으로써, 피부 염증 억제 효과를 나타낼 수 있다.In addition, by containing abundant polyphenol-based physiologically active substances, it is possible to exhibit a skin inflammation inhibitory effect.
본 발명에 따른 화장료 조성물은, 잣나무 목재 추출물, 케나프 추출물 및 잣나무 잎 추출물을 동시 포함함으로써, 항산화, 미백, 주름 개선 및 염증 억제 기능을 동시 확보할 수 있는 특징이 있다.The cosmetic composition according to the present invention is characterized in that anti-oxidation, whitening, anti-wrinkle and anti-inflammatory functions can be secured at the same time by including pine nut wood extract, kenaf extract and pine nut leaf extract at the same time.
일 실시형태에 따르면, 상기 혼합물 100 중량부에 대하여, 상기 잣나무 잎 에탄올 추출물은 10 중량부 내지 100 중량부로 포함되는 것일 수 있다.According to one embodiment, with respect to 100 parts by weight of the mixture, the pine nut leaf ethanol extract may be included in 10 parts by weight to 100 parts by weight.
바람직하게는, 상기 혼합물 100 중량부에 대하여, 상기 잣나무 잎 에탄올 추출물은 10 중량부 내지 80 중량부로 포함되는 것일 수 있고, 더욱 바람직하게는, 30 중량부 내지 70 중량부로 포함되는 것일 수 있다.Preferably, with respect to 100 parts by weight of the mixture, the pine nut leaf ethanol extract may be included in 10 parts by weight to 80 parts by weight, more preferably, 30 parts by weight to 70 parts by weight.
상기 잣나무 잎 에탄올 추출물의 함량 범위는, 잣나무 목재 추출물 및 케나프 추출물의 효능을 저하시키지 않으면서 주름 개선 및 염증 억제 기능을 동시에 확보할 수 있는 최적 함량 범위이다.The content range of the pine nut leaf ethanol extract is an optimal content range that can secure anti-wrinkle and anti-inflammatory functions at the same time without reducing the efficacy of the pine nut extract and the kenaf extract.
일 실시형태에 따르면, 상기 화장료 조성물은, 병풀 추출물, 프로폴리스 추출물, 어성초 추출물, 녹차잎 추출물, 맥문동 추출물 및 구기자 추출물로 이루어진 군에서 선택되는 하나 이상의 식물성 추출물을 유효 성분으로 더 포함하는 것일 수 있다.According to one embodiment, the cosmetic composition may further include, as an active ingredient, one or more vegetable extracts selected from the group consisting of centella asiatica extract, propolis extract, houttuynia cordata extract, green tea leaf extract, walnut extract, and wolfberry extract. .
일 실시형태에 따르면, 상기 혼합물 100 중량부에 대하여, 상기 식물성 추출물은 1 중량부 내지 30 중량부로 포함되는 것일 수 있다.According to one embodiment, based on 100 parts by weight of the mixture, the vegetable extract may be included in 1 part by weight to 30 parts by weight.
바람직하게는, 상기 혼합물 100 중량부에 대하여, 상기 식물성 추출물은 1 중량부 내지 20 중량부로 포함되는 것일 수 있다.Preferably, based on 100 parts by weight of the mixture, the vegetable extract may be included in 1 part by weight to 20 parts by weight.
상기 식물성 추출물은, 본 발명에 따른 화장료 조성물의 항산화, 미백, 항진균 효과 등을 더욱 증진시킬 수 있으며, 잣나무 목재 추출물, 케나프 추출물 또는 잣나무 잎 추출물 내 포함되지 않은 다른 유효성분들을 적정 수준으로 제공함으로써, 항산화, 미백, 주름개선, 수렴, 모공수축, 항염증 기능을 향상시키는 역할을 수행할 수 있다.The vegetable extract can further enhance the antioxidant, whitening, and antifungal effects of the cosmetic composition according to the present invention, and provides other active ingredients not included in the pine nut extract, kenaf extract, or pine nut leaf extract at an appropriate level. , It can play a role in improving antioxidant, whitening, wrinkle improvement, convergence, pore contraction, and anti-inflammatory function.
병풀(Centella Asiatica)은, 미나리과에 속하는 다년생 식물로 아 시아틱산(Asiatic acid), 아시아티코사이드(Asiaticoside), 마데카식애씨드(Madecassic acid)를 주요성분으로 포함하며, 상기 병풀 추출물은 항산화, 피부트러블 예방, 노화 예방, 피부 재생에 효과적이다. Centella Asiatica is a perennial plant belonging to the Apiaceae family and contains Asiatic acid, Asiaticoside, and Madecassic acid as main components. It is effective for prevention, anti-aging, and skin regeneration.
프로폴리스는, 꿀벌의 집을 구성하는 물질 중 하나로 벌집 주위에 발라져 있는 황록색, 암갈색의 끈적끈적한 물질로, 상기 프로폴리스 추출물은 항생, 항염, 항산화 효과를 갖는다.Propolis is a yellowish green, dark brown sticky substance that is applied around the beehive as one of the substances constituting the bee's nest, and the propolis extract has antibiotic, anti-inflammatory, and antioxidant effects.
어성초는 삼백초과의 식물로 약모밀이라도고 하며, 주요성분으로는 Flavonoid로서 quercetin, quercitrin, isoquercetin, afzerin, rutin, Alkaloid로서 aristolactam A, AII, B, BII, piperolactam A, norcepharadione B, cepharadione B, splendidine 등이 있다. 상기 어성초 추출물은 항산화, 항염증, 미백, 피부 재생에 효과적이다. Eoseongcho is a plant in the family of more than 300 and is called medicinal buckwheat. Its main components include quercetin, quercitrin, isoquercetin, afzerin, rutin as flavonoids, and aristolactam A, AII, B, BII, piperolactam A, norcepharadione B, cepharadione B, and splendidine as alkaloids. there is. The Eoseongcho extract is effective in antioxidant, anti-inflammatory, whitening, and skin regeneration.
녹차잎은 레본보다 5~8배 많은 비타민 C가 함유되어 있어 기미나 주근깨를 억제하고 피부에 진정작용과 동시에 유해산소를 제거해 피부 노화를 방지하는데 효과적이며, 녹차잎 추출물은 항산화, 미백, 수렴, 모공수축, 항염증 효과를 증진시킬 수 있다.Green tea leaves contain 5 to 8 times more vitamin C than Levon, so it is effective in suppressing freckles and freckles, soothing the skin and removing free radicals to prevent skin aging. It can enhance pore contraction and anti-inflammatory effects.
맥문동(Liriopeplatyphylla Wang et Tang)은 백합과에 속하는 다년생 초본식물로서, 상기 맥문동 추출물은 항염증 효과를 향상시킨다. Liriopeplatyphylla Wang et Tang is a perennial herbaceous plant belonging to the Liliaceae family, and the extract of Liriopeplatyphylla Wang et Tang improves the anti-inflammatory effect.
구기자란 구기자 나무(Lycium chinense)의 열매로, betaine, cholin, physalien, rutin, βzeazanthin 등 다양한 기능성 성분을 함유하고 있으며, 상기 구기자 추출물은 항산화 및 항균 효과를 향상시킬 수 있다.It is a fruit of the goji berry tree ( Lycium chinense ) and contains various functional ingredients such as betaine, cholin, physalien, rutin, and β zeazanthin, and the goji berry extract can improve antioxidant and antibacterial effects.
일 실시형태에 따르면, 상기 식물성 추출물은, 병풀 추출물 1 중량부 내지 10 중량부, 프로폴리스 추출물 1 중량부 내지 8 중량부, 어성초 추출물 1 중량부 내지 5 중량부, 녹차잎 추출물 1 중량부 내지 5 중량부, 맥문동 추출물 1 중량부 내지 3 중량부 및 구기자 추출물 1 중량부 내지 3 중량부를 포함하는 것일 수 있다.According to one embodiment, the vegetable extract,
상기 식물성 추출물 내 포함된 각 성분의 함량범위는, 각 추출물 내 유효성분이 가진 기능을 최대화하면서, 각 성분 간의 상호작용으로 인해 발생할 수 있는 부작용을 최소화할 수 있는 범위에 해당한다.The content range of each component included in the vegetable extract corresponds to a range that can minimize side effects that may occur due to interactions between each component while maximizing the function of the active ingredient in each extract.
일 실시형태에 따르면, 상기 화장료 조성물은, 항산화용, 미백용, 주름개선용, 수렴용, 모공수축용 또는 염증 억제용인 것일 수 있다.According to one embodiment, the cosmetic composition may be for antioxidant, whitening, wrinkle improvement, convergence, pore contraction, or inflammation inhibition.
본 발명에 따른 화장료 조성물은, 상기 유효성분 이외에 화장료 조성물에 통상적으로 사용되는 항산화제, 안정화제, 용해화제, 비타민, 안료, 향료 등과 같은 통상적인 보조제 및 담체가 더 포함될 수 있다. 예를 들어 상기 화장료 조성물에는 글리세린, 부틸렌 글라이콜, 폴리옥시에칠렌 경화피마자유, 토코페릴 아세테이트, 시트릭산, 판테놀, 스쿠알란, 소듐 시트레이트, 알란토인 등의 보조 성분이 추가로 더 포함될 수 있다.The cosmetic composition according to the present invention may further include conventional adjuvants and carriers such as antioxidants, stabilizers, solubilizers, vitamins, pigments, fragrances, etc., which are commonly used in cosmetic compositions, in addition to the above active ingredients. For example, the cosmetic composition may further include auxiliary ingredients such as glycerin, butylene glycol, polyoxyethylene hydrogenated castor oil, tocopheryl acetate, citric acid, panthenol, squalane, sodium citrate, and allantoin.
또한, 유지 성분, 보습제, 에몰리엔트제, 계면 활성제, 유기 및 무기 안료, 유기 분체, 자외선 흡수제, 방부제, 살균제, 산화 방지제, 식물 추출물, pH 조정제, 알콜, 색소, 향료, 혈행촉진제, 냉감제, 제한(制汗)제, 정제수 등의 배합 성분이 포함될 수 있다.In addition, oil and fat ingredients, humectants, emollients, surfactants, organic and inorganic pigments, organic powders, ultraviolet absorbers, preservatives, bactericides, antioxidants, plant extracts, pH adjusters, alcohols, pigments, fragrances, blood circulation promoters, cooling agents , Antiperspirants, purified water and other ingredients may be included.
유지 성분으로서는 에스테르계 유지, 탄화수소계 유지, 실리콘계 유지, 불소계 유지, 동물 유지, 식물 유지 등을 들 수 있다.Examples of the oil and fat component include ester oils, hydrocarbon oils, silicone oils, fluorine oils, animal fats and vegetable oils.
에스테르계 유지로서는 트리2-에틸헥산산글리세릴, 2-에틸헥산산세틸, 미리스틴산이소프로필, 미리스틴산부틸, 팔미틴산이소프로필, 스테아르산에틸, 팔미틴산옥틸, 이소스테아르산이소세틸, 스테아르산부틸, 리놀레산에틸, 리놀레산이소프로필, 올레인산에틸, 미리스틴산이소세틸, 미리스틴산이소스테아릴, 팔미틴산이소스테아릴, 미리스틴산옥틸도데실, 이소스테아르산이소세틸, 세바신산디에틸, 아디핀산디이소프로필, 네오펜탄산이소알킬, 트리(카프릴, 카프린산)글리세릴, 트리2-에틸헥산산트리메틸롤프로판, 트리이소스테아르산트리메틸롤프로판, 테트라2-에틸헥산산펜타엘리슬리톨, 카프릴산세틸, 라우린산데실, 라우린산헥실, 미리스틴산데실, 미리스틴산미리스틸, 미리스틴산세틸, 스테아르산스테아릴, 올레인산데실, 리시노올레인산세틸, 라우린산이소스테아릴, 미리스틴산이소트리데실, 팔미틴산이소세틸, 스테아르산옥틸, 스테아르산이소세틸, 올레인산이소데실, 올레인산옥틸도데실, 리놀레산옥틸도데실, 이소스테아르산이소프로필, 2-에틸헥산산세토스테아릴, 2-에틸헥산산스테아릴, 이소스테아르산헥실, 디옥탄산에틸렌글리콜, 디올레인산에틸렌글리콜, 디카프린산프로필렌글리콜, 디(카프릴,카프린산)프로필렌글리콜, 디카프릴산프로필렌글리콜, 디카프린산네오펜틸글리콜, 디옥탄산네오펜틸글리콜, 트리카프릴산글리세릴, 트리운데실산글리세릴, 트리이소팔미틴산글리세릴, 트리이소스테아르산글리세릴, 네오펜탄산옥틸도데실, 옥탄산이소스테아릴, 이소노난산옥틸, 네오데칸산헥실데실, 네오데칸산옥틸도데실, 이소스테아르산이소세틸, 이소스테아르산이소스테아릴, 이소스테아르산옥틸데실, 폴리글리세린올레인산에스테르, 폴리글리세린이소스테아르산에스테르, 시트르산트리이소세틸, 시트르산트리이소알킬, 시트르산트리이소옥틸, 락트산라우릴, 락트산미리스틸, 락트산세틸, 락트산옥틸데실, 시트르산트리에틸, 시트르산아세틸트리에틸, 시트르산아세틸트리부틸, 시트르산트리옥틸, 말산디이소스테아릴, 히드록시스테아르산 2-에틸헥실, 숙신산디2-에틸헥실, 아디핀산디이소부틸, 세바신산디이소프로필, 세바신산디옥틸, 스테아르산콜레스테릴, 이소스테아르산콜레스테릴, 히드록시스테아르산콜레스테릴, 올레인산콜레스테릴, 올레인산디히드로콜레스테릴, 이소스테아르산피트스테릴, 올레인산피트스테릴, 12-스테알로일히드록시스테아르산이소세틸, 12-스테알로일히드록시스테아르산스테아릴, 12-스테알로일히드록시스테아르산이소스테아릴 등의 에스테르계 등을 들 수 있다.Examples of ester oils include glyceryl tri-2-ethylhexanoate, cetyl 2-ethylhexanoate, isopropyl myristate, butyl myristate, isopropyl palmitate, ethyl stearate, octyl palmitate, isocetyl isostearate, and stearic acid. Butyl, ethyl linoleate, isopropyl linoleate, ethyl oleate, isocetyl myristate, isostearyl myristate, isostearyl palmitate, octyldodecyl myristate, isocetyl isostearate, diethyl sebacate, adipine Diisopropyl acid, isoalkyl neopentanoate, tri(capryl, capric acid) glyceryl, trimethylolpropane tri2-ethylhexanoate, trimethylolpropane triisostearate, pentaelislitol tetra2-ethylhexanoate , Cetyl caprylate, decyl laurate, hexyl laurate, decyl myristate, myristyl myristate, cetyl myristate, stearyl stearate, decyl oleate, cetyl ricinooleate, isostea laurate Lil, isotridecyl myristate, isocetyl palmitate, octyl stearate, isocetyl stearate, isodecyl oleate, octyldodecyl oleate, octyldodecyl linoleate, isopropyl isostearate, 2-ethylhexanoate Aryl, 2-ethyl stearyl hexanoate, hexyl isostearate, ethylene glycol dioctanoate, ethylene glycol dioleate, propylene glycol dicaprate, di(caprylic, capric acid) propylene glycol, propylene glycol dicaprylate, dicap Neopentyl glycol prinate, neopentyl glycol dioctanoate, glyceryl tricaprylate, glyceryl triundecylate, glyceryl triisopalmitate, glyceryl triisostearate, octyldodecyl neopentanoate, isostearyl octanoate , Octyl isononanoate, hexyldecyl neodecanoate, octyldodecyl neodecanoate, isocetyl isostearate, isostearyl isostearate, octyldecyl isostearate, polyglycerin oleate, polyglycerin isostearate, Triisocetyl citrate, triisoalkyl citrate, triisooctyl citrate, lauryl lactate, myristyl lactate, cetyl lactate, octyldecyl lactate, triethyl citrate, acetyltriethyl citrate, acetyltributyl citrate, trioctyl citrate, dimalate Isostearyl, 2-ethylhexyl hydroxystearate, di2-ethylhexyl succinate, diisobutyl adipate, diisopropyl sebacate, dioctyl sebacate, Cholesteryl stearate, cholesteryl isostearate, cholesteryl hydroxystearate, cholesteryl oleate, dihydrocholesteryl oleate, phyteryl isostearate, phyteryl oleate, 12-stealoyl and esters such as isocetyl hydroxystearate, stearyl 12-stealoylhydroxystearate, and isostearyl 12-stealoylhydroxystearate.
탄화 수소계 유지로서는 스쿠알렌, 유동 파라핀, 알파-올레핀올리고머, 이소파라핀, 세레신, 파라핀, 유동 이소파라핀, 폴리부덴, 마이크로크리스탈린왁스, 와셀린 등의 탄화 수소계 유지 등을 들 수 있다.Examples of hydrocarbon-based fats and oils include hydrocarbon-based fats and oils such as squalene, liquid paraffin, alpha-olefin oligomer, isoparaffin, ceresin, paraffin, liquid isoparaffin, polybuden, microcrystalline wax, and vaseline.
실리콘계 유지로서는 폴리메틸실리콘, 메틸페닐실리콘, 메틸시클로폴리실록산, 옥타메틸폴리실록산, 데카메틸폴리실록산, 도데카메틸시클로실록산, 디메틸실록산ㆍ메틸세틸옥시실록산 공중합체, 디메틸실록산ㆍ메틸스테알록시실록산 공중합체, 알킬 변성 실리콘유, 아미노 변성 실리콘유 등을 들 수 있다.Examples of silicone oils include polymethylsilicone, methylphenylsilicone, methylcyclopolysiloxane, octamethylpolysiloxane, decamethylpolysiloxane, dodecamethylcyclosiloxane, dimethylsiloxane/methylcetyloxysiloxane copolymer, dimethylsiloxane/methylstealoxysiloxane copolymer, alkyl Modified silicone oil, amino modified silicone oil, etc. are mentioned.
불소계 유지로서는 퍼플루오로폴리에테르 등을 들 수 있다.Examples of fluorine-based fats and oils include perfluoropolyether and the like.
동물 또는 식물 유지로서는 아보카도유, 아르몬드유, 올리브유, 참깨유, 쌀겨유, 새플라워유, 대두유, 옥수수유, 유채유, 행인(杏仁)유, 팜핵유, 팜유, 피마자유, 해바라기유, 포도종자유, 면실유, 야자유, 쿠쿠이너트유, 소맥배아유, 쌀 배아유, 시아버터, 월견초유, 마커데이미아너트유, 메도홈유, 난황유, 우지(牛脂), 마유, 밍크유, 오렌지라피유, 호호바유, 캔데리러왁스, 카르나바왁스, 액상 라놀린, 경화피마자유 등의 동물 또는 식물 유지를 들 수 있다.Animal or vegetable oils include avocado oil, almond oil, olive oil, sesame oil, rice bran oil, birdflower oil, soybean oil, corn oil, rapeseed oil, algae oil, palm kernel oil, palm oil, castor oil, sunflower oil, grape seed oil , cottonseed oil, palm oil, kukui nut oil, wheat germ oil, rice germ oil, shea butter, moonshine colostrum, marker damian nut oil, meadowsweet oil, egg yolk oil, beef tallow, horse oil, mink oil, orange raffia oil, jojoba oil , animal or plant fats and oils such as candelilla wax, carnaba wax, liquid lanolin, and hydrogenated castor oil.
보습제로서는 수용성 저분자 보습제, 지용성 분자 보습제, 수용성 고분자, 지용성 고분자 등을 들 수 있다.Examples of the moisturizer include water-soluble low-molecular moisturizers, fat-soluble molecular moisturizers, water-soluble polymers, and oil-soluble polymers.
수용성 저분자 보습제로서는 세린, 글루타민, 솔비톨, 만니톨, 피롤리돈-카르복실산나트륨, 글리세린, 프로필렌글리콜, 1,3-부틸렌글리콜, 에틸렌글리콜, 폴리에틸렌글리콜B(중합도 n=2 이상), 폴리프로필렌글리콜(중합도 n=2 이상), 폴리글리세린B(중합도 n=2 이상), 락트산, 락트산염 등을 들 수 있다.Examples of water-soluble low-molecular moisturizers include serine, glutamine, sorbitol, mannitol, pyrrolidone-sodium carboxylate, glycerin, propylene glycol, 1,3-butylene glycol, ethylene glycol, polyethylene glycol B (polymerization degree n = 2 or more), polypropylene Glycol (polymerization degree n = 2 or more), polyglycerol B (polymerization degree n = 2 or more), lactic acid, lactate, etc. are mentioned.
지용성 저분자 보습제로서는 콜레스테롤, 콜레스테롤에스테르 등을 들 수 있다. Cholesterol, cholesterol ester, etc. are mentioned as a fat-soluble low-molecular moisturizer.
수용성 고분자로서는 카르복시비닐폴리머, 폴리아스파라긴산염, 트라가칸트, 크산탄검, 메틸셀룰로오스, 히드록시메틸셀룰로오스, 히드록시에틸셀룰로오스, 히드록시프로필셀룰로오스, 카르복시메틸셀룰로오스, 수용성 키틴, 키토산, 덱스트린 등을 들 수 있다. 지용성 고분자로서는 폴리비닐피롤리돈ㆍ에이코센 공중합체, 폴리비닐피롤리돈ㆍ헥사데센 공중합체, 니트로셀룰로오스, 덱스트린지방산에스테르, 고분자 실리콘 등을 들 수 있다.Examples of water-soluble polymers include carboxyvinyl polymer, polyaspartate, tragacanth, xanthan gum, methyl cellulose, hydroxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, carboxymethyl cellulose, water-soluble chitin, chitosan, dextrin, and the like. can Examples of the fat-soluble polymer include polyvinylpyrrolidone/eicosene copolymer, polyvinylpyrrolidone/hexadecene copolymer, nitrocellulose, dextrin fatty acid ester, and high molecular silicone.
에몰리엔트제로서는 장쇄아실글루타민산콜레스테릴에스테르, 히드록시스테아르산콜레스테릴, 12-히드록시스테아르산, 스테아르산, 로진산, 라놀린지방산콜레스테릴에스테르 등을 들 수 있다.Examples of the emollient agent include long-chain acyl glutamic acid cholesteryl ester, hydroxystearic acid cholesteryl, 12-hydroxystearic acid, stearic acid, rosin acid, lanolin fatty acid cholesteryl ester, and the like.
계면 활성제로서는 비이온성 계면 활성제, 음이온성 계면 활성제, 양이온성 계면 활성제, 양성 계면 활성제 등을 들 수 있다.Examples of the surfactant include nonionic surfactants, anionic surfactants, cationic surfactants, and amphoteric surfactants.
비이온성 계면 활성제로서는 자기 유화형 모노스테아르산글리세린, 프로필렌글리콜지방산에스테르, 글리세린지방산에스테르, 폴리글리세린지방산에스테르, 솔비탄지방산에스테르, POE (폴리옥시에틸렌)솔비탄지방산에스테르, POE 솔비트지방산에스테르, POE 글리세린지방산에스테르, POE 알킬에테르, POE 지방산에스테르, POE 경화피마자유, POE 피마자유, POEㆍPOP (폴리옥시에틸렌ㆍ폴리옥시프로필렌) 공중합체, POEㆍPOP 알킬에테르, 폴리에테르변성실리콘, 라우린산알카놀아미드, 알킬아민옥시드, 수소첨가대두인지질 등을 들 수 있다.Nonionic surfactants include self-emulsifying glycerin monostearate, propylene glycol fatty acid esters, glycerin fatty acid esters, polyglycerin fatty acid esters, sorbitan fatty acid esters, POE (polyoxyethylene) sorbitan fatty acid esters, POE sorbitan fatty acid esters, POE Glycerin fatty acid ester, POE alkyl ether, POE fatty acid ester, POE hydrogenated castor oil, POE castor oil, POE·POP (polyoxyethylene·polyoxypropylene) copolymer, POE·POP alkyl ether, polyether modified silicone, lauric acid alkanolamides, alkylamine oxides, hydrogenated soybean phospholipids, and the like.
음이온성 계면 활성제로서는 지방산비누, 알파-아실술폰산염, 알킬술폰산염, 알킬알릴술폰산염, 알킬나프탈렌술폰산염, 알킬황산염, POE 알킬에테르황산염, 알킬아미드황산염, 알킬인산염, POE 알킬인산염, 알킬아미드인산염, 알킬로일알킬타우린염, N-아실아미노산염, POE 알킬에테르카르복실산염, 알킬술포숙신산염, 알킬술포아세트산나트륨, 아실화 가수분해 콜라겐펩티드염, 퍼플루오로알킬인산에스테르 등을 들 수 있다.Anionic surfactants include fatty acid soaps, alpha-acyl sulfonates, alkyl sulfonates, alkyl allyl sulfonates, alkyl naphthalene sulfonates, alkyl sulfates, POE alkyl ether sulfates, alkyl amide sulfates, alkyl phosphates, POE alkyl phosphates, and alkyl amide phosphates. , alkyloylalkyl taurine salts, N-acylamino acid salts, POE alkyl ether carboxylate salts, alkyl sulfosuccinic acid salts, sodium alkyl sulfoacetate, acylated hydrolyzed collagen peptide salts, perfluoroalkyl phosphate esters, and the like. .
양이온성 계면 활성제로서는 염화알킬트리메틸암모늄, 염화스테아릴트리메틸암모늄, 브롬화스테아릴트리메틸암모늄, 염화세토스테아릴트리메틸암모늄, 염화디스테아릴디메틸암모늄, 염화스테아릴디메틸벤질암모늄, 브롬화베헤닐트리메틸암모늄, 염화벤잘코늄, 스테아르산디에틸아미노에틸아미드, 스테아르산디메틸아미노프로필아미드, 라놀린 유도체 제4급 암모늄염 등을 들 수 있다.As the cationic surfactant, alkyltrimethylammonium chloride, stearyltrimethylammonium chloride, stearyltrimethylammonium bromide, cetostearyltrimethylammonium chloride, distearyldimethylammonium chloride, stearyldimethylbenzylammonium chloride, behenyltrimethylammonium bromide, chloride Benzalkonium, stearic acid diethylaminoethylamide, stearic acid dimethylaminopropylamide, lanolin derivative quaternary ammonium salt, etc. are mentioned.
양성 계면 활성제로서는 카르복시베타인형, 아미드베타인형, 술포베타인형, 히드록시술포베타인형, 아미드술포베타인형, 포스포베타인형, 아미노카르복실산염형, 이미다졸린 유도체형, 아미드아민형 등의 양성 계면 활성제 등을 들 수 있다.Amphoteric surfactants include carboxybetaine type, amidebetaine type, sulfobetaine type, hydroxysulfobetaine type, amide sulfobetaine type, phosphobetaine type, aminocarboxylate type, imidazoline derivative type, amideamine type, etc. An amphoteric surfactant etc. are mentioned.
유기 및 무기 안료로서는 규산, 무수규산, 규산마그네슘, 탤크, 세리사이트, 마이카, 카올린, 벵갈라, 클레이, 벤토나이트, 티탄피막운모, 옥시염화비스무트, 산화지르코늄, 산화마그네슘, 산화아연, 산화티탄, 산화알루미늄, 황산칼슘, 황산바륨, 황산마그네슘, 탄산칼슘, 탄산마그네슘, 산화철, 군청, 산화크롬, 수산화크롬, 칼라민 및 이들의 복합체등의 무기 안료, 폴리아미드, 폴리에스테르, 폴리프로필렌, 폴리스티렌, 폴리우레탄, 비닐수지, 요소수지, 페놀수지, 불소수지, 규소수지, 아크릴수지, 멜라민수지, 에폭시수지, 폴리카보네이트수지, 디비닐벤젠ㆍ스티렌 공중합체, 실크파우더, 셀룰로오스, CI 피그먼트옐로우, CI 피그먼트오렌지 등의 유기 안료 및 이들의 무기 안료와 유기 안료의 복합 안료 등을 들 수 있다.As organic and inorganic pigments, silicic acid, silicic anhydride, magnesium silicate, talc, sericite, mica, kaolin, bengala, clay, bentonite, titanium-coated mica, bismuth oxychloride, zirconium oxide, magnesium oxide, zinc oxide, titanium oxide, aluminum oxide , inorganic pigments such as calcium sulfate, barium sulfate, magnesium sulfate, calcium carbonate, magnesium carbonate, iron oxide, ultramarine blue, chromium oxide, chromium hydroxide, calamine and their complexes, polyamide, polyester, polypropylene, polystyrene, polyurethane , vinyl resin, urea resin, phenol resin, fluorine resin, silicon resin, acrylic resin, melamine resin, epoxy resin, polycarbonate resin, divinylbenzene styrene copolymer, silk powder, cellulose, CI pigment yellow, CI pigment organic pigments such as orange, composite pigments of these inorganic pigments and organic pigments, and the like are exemplified.
유기 분체로서는 스테아르산칼슘 등의 금속비누, 세틸린산아연나트륨, 라우릴린산아연, 라우릴린산칼슘 등의 알킬인산금속염, N-라우로일-베타-알라닌칼슘, N-라우로일-베타-알라닌아연, N-라우로일글리신칼슘 등의 아실아미노산 다가금속염, N-라우로일-타우린칼슘, N-팔미토일-타우린칼슘 등의 아미드술폰산 다가금속염, N-엡실론-라우로일-L-리진, N-엡실론-팔미토일리진, N-알파-파리토일올니틴, N-알파-라우로일아르기닌, N-알파-경화우지지방산아실아르기닌 등의 N-아실염기성아미노산, N-라우로일글리실글리신 등의 N-아실폴리펩티드, 알파-아미노카프릴산, 알파-아미노라우린산 등의 알파-아미노지방산, 폴리에틸렌, 폴리프로필렌, 나일론, 폴리메틸메타크릴레이트, 폴리스티렌, 디비닐벤젠ㆍ스티렌 공중합체, 사불화에틸렌 등을 들 수 있다.As the organic powder, metal soaps such as calcium stearate, zinc sodium cetylate, zinc laurylate, calcium laurylate, etc., metal alkylphosphates, N-lauroyl-beta-alanine calcium, N-lauroyl-beta- Acylamino acid polyvalent metal salts such as zinc alanine and calcium N-lauroylglycine, polyvalent metal salts of amide sulfonic acids such as calcium N-lauroyl-taurine and calcium N-palmitoyl-taurine, N-epsilon-lauroyl-L- N-acyl basic amino acids such as lysine, N-epsilon-palmitoylizine, N-alpha-paritoylolnithine, N-alpha-lauroylarginine, and N-alpha-hydrogenated beef tallow fatty acid acylarginine, N-lauroyl glycol N-acyl polypeptides such as lysylglycine, alpha-amino fatty acids such as alpha-aminocaprylic acid and alpha-aminolauric acid, polyethylene, polypropylene, nylon, polymethyl methacrylate, polystyrene, divinylbenzene/styrene copolymer A polymer, ethylene tetrafluoride, etc. are mentioned.
자외선 흡수제로서는 파라아미노벤조산, 파라아미노벤조산에틸, 파라아미노벤조산아밀, 파라아미노벤조산옥틸, 살리실산에틸렌글리콜, 살리신산페닐, 살리신산옥틸, 살리신산벤질, 살리신산부틸페닐, 살리신산호모멘틸, 계피산벤질, 파라메톡시계피산-2-에톡시에틸, 파라메톡시계피산옥틸, 디파라메톡시계피산모노-2-에틸헥산글리세릴, 파라메톡시계피산이소프로필, 디이소프로필ㆍ디이소프로필계피산에스테르 혼합물, 우로카닌산, 우로카닌산에틸, 히드록시메톡시벤조페논, 히드록시메톡시벤조페논술폰산 및 그 염, 디히드록시메톡시벤조페논, 디히드록시메톡시벤조페논디술폰산나트륨, 디히드록시벤조페논, 테트라히드록시벤조페논, 4-tert-부틸-4'-메톡시디벤조일메탄, 2,4,6-트리아닐리노-p-(카르보-2'-에틸헥실-1'-옥시)-1,3,5-트리아진, 2-(2-히드록시-5-메틸페닐)벤조트리아졸 등을 들 수 있다.Examples of UV absorbers include para-aminobenzoic acid, ethyl para-aminobenzoate, amyl para-aminobenzoate, octyl para-aminobenzoate, ethylene glycol salicylate, phenyl salicylate, octyl salicylate, benzyl salicylate, butylphenyl salicylate, homomenthyl salicylate, and benzyl cinnamate. , paramethoxycinnamic acid-2-ethoxyethyl, paramethoxycinnamic acid octyl, diparamethoxycinnamic acid mono-2-ethylhexane glyceryl, paramethoxycinnamic acid isopropyl, diisopropyl-diisopropylcinnamic acid ester mixture, uro Cannic acid, ethyl urocanate, hydroxymethoxybenzophenone, hydroxymethoxybenzophenonesulfonic acid and its salts, dihydroxymethoxybenzophenone, dihydroxymethoxybenzophenone sodium disulfonate, dihydroxybenzophenone , tetrahydroxybenzophenone, 4-tert-butyl-4'-methoxydibenzoylmethane, 2,4,6-trianilino-p-(carbo-2'-ethylhexyl-1'-oxy)-1 ,3,5-triazine, 2-(2-hydroxy-5-methylphenyl)benzotriazole, etc. are mentioned.
살균제로서는 히노키티올, 트리클로산, 트리클로로히드록시디페닐에테르, 크로르헥시딘글루콘산염, 페녹시에탄올, 레조르신, 이소프로필메틸페놀, 아줄렌, 살리칠산, 진크필리티온, 염화벤잘코늄, 감광소 301호, 모노니트로과이어콜나트륨, 운데시렌산 등을 들 수 있다.Bactericides include hinokitiol, triclosan, trichlorohydroxydiphenyl ether, chlorhexidine gluconate, phenoxyethanol, resorcin, isopropylmethylphenol, azulene, salicylic acid, zincophylthione, benzalkonium chloride, photosensitizer So No. 301, mononitroguacol sodium, undecyrenic acid, etc. are mentioned.
산화 방지제로서는 부틸히드록시아니솔, 갈릭산프로필, 엘리소르빈산 등을 들 수 있다.Examples of antioxidants include butylhydroxyanisole, propyl gallic acid, and elisorbic acid.
pH 조정제로서는 시트르산, 시트르산나트륨, 말산, 말산나트륨, 프말산, 프말산나트륨, 숙신산, 숙신산나트륨, 수산화나트륨, 인산일수소나트륨 등을 들 수 있다. Examples of the pH adjuster include citric acid, sodium citrate, malic acid, sodium malate, fumaric acid, sodium fumalate, succinic acid, sodium succinate, sodium hydroxide, and sodium monohydrogenphosphate.
알코올로서는 세틸알코올 등의 고급 알코올을 들 수 있다.Examples of alcohol include higher alcohols such as cetyl alcohol.
상기 화장료 조성물 내 배합 성분은 이에 한정되는 것은 아니며, 상기 어느 성분도 본 발명의 목적 및 효과를 손상시키지 않는 범위 내에서 배합 가능하지만, 바람직하게는 총중량에 대하여 0.01 중량% 내지 5 중량%, 더욱 바람직하게는, 0.01 중량% 내지 3 중량%로 배합될 수 있다.The ingredients in the cosmetic composition are not limited thereto, and any of the above ingredients can be blended within a range that does not impair the object and effect of the present invention, but is preferably 0.01% to 5% by weight relative to the total weight, more preferably may be blended in an amount of 0.01% to 3% by weight.
본 발명에 따른 화장료 조성물은, 용액, 외용연고, 크림, 폼, 영양화장수, 유연화장수, 팩, 유연수, 유 액, 메이크업베이스, 에센스, 비누, 액체 세정료, 입욕제, 선 스크린크림, 선오일, 현탁액, 유탁액, 페이스트, 겔, 로션, 파우더, 비누, 계면활성제-함유 클린싱, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이 션, 패취 및 스프레이로 구성된 군으로부터 선택되는 제형으로 제조할 수 있으나 이에 제한되는 것은 아니다.The cosmetic composition according to the present invention is a solution, external ointment, cream, foam, nutrient lotion, softening lotion, pack, softening water, emulsion, makeup base, essence, soap, liquid cleanser, bath additive, sunscreen cream, sun oil, Suspensions, emulsions, pastes, gels, lotions, powders, soaps, surfactant-containing cleansers, oils, powder foundations, emulsion foundations, wax foundations, patches and sprays may be prepared in formulations selected from the group consisting of It is not limited thereto.
일 실시형태에 따르면, 상기 화장료는, 화장수, 토너, 스킨, 로션, 에멀젼, 크림, 에센스, 세럼, 젤 및 팩으로 이루어지는 군으로부터 선택되는 어느 하나인 기초 화장료, 립스틱, 틴트, 립글로우, 립밤, 비비크림, 파운데이션, 파우더, 마스카라, 아이쉐도우 및 아이라이너로부터 선택되는 메이크업 화장료, 피부각질 스크럽, 클렌징워터, 클렌징오일, 클렌징크림 및 폼클렌징으로 이루어지는 군으로부터 선택되는 어느 하나인 세정용 화장료, 샴푸, 린스 및 트리트먼트로 이루어지는 군으로부터 선택되는 어느 하나인 모발용 화장료, 및 바디스크럽, 바디로션, 바디크림, 및 바디워시로 이루어지는 군으로부터 선택되는 어느 하나인 바디용 화장료,로 이루어지는 군으로부터 선택되는 하나 이상을 포함하는 것일 수 있다.According to one embodiment, the cosmetic is any one of basic cosmetics selected from the group consisting of lotion, toner, skin, lotion, emulsion, cream, essence, serum, gel, and pack, lipstick, tint, lip glow, lip balm, Cosmetics for washing, shampoo, At least one selected from the group consisting of cosmetics for hair, which is any one selected from the group consisting of rinse and treatment, and cosmetics for body, which is any one selected from the group consisting of body scrub, body lotion, body cream, and body wash It may contain.
이하, 실시예 및 비교예에 의하여 본 발명을 더욱 상세히 설명하고자 한다.Hereinafter, the present invention will be described in more detail by examples and comparative examples.
단, 하기 실시예는 본 발명을 예시하기 위한 것일 뿐, 본 발명의 내용이 하기 실시예에 한정되는 것은 아니다.However, the following examples are only for illustrating the present invention, and the content of the present invention is not limited to the following examples.
<실시예> 잣나무 목재 추출물 및 케나프 추출물을 포함하는 화장료 조성물의 제조<Example> Preparation of a cosmetic composition containing pine wood extract and kenaf extract
1) 잣나무 목재 추출물 및 케나프 추출물의 혼합물 제조1) Preparation of a mixture of pine wood extract and kenaf extract
잣나무 목재와 케나프 지상부를 각각 5 kg씩 채취하여 자연 음지 건조후 분쇄하였다. 분쇄한 시료에 시료 중량의 10배 양의 에탄올 70 %(v/v)을 가하여 실온에서 약 24시간 침지한 후 상등액과 침전물을 분리하여 동일한 방법으로 3회 반복 추출하였다. 각 시료 추출물은 여과지(Whatman No.2)를 이용하여 여과한 후 EYELA 증발기(evaporator)로 감압 농축하여 용매를 제거 후 동결 건조하였으며, 이 시료를 -20 ℃ 온도에서 보관하였다. 이후 동결건조한 잣나무 목재 추출물 및 케나프 지상부 추출물을 1:1로 혼합하여 혼합물(시료용액)을 제조하였다.5 kg each of pine nut timber and kenaf aerial parts were collected, dried in a natural shade, and then pulverized. After adding 70% (v/v) of
2) 화장료 조성물의 제조2) Preparation of cosmetic composition
상기 제조된 혼합물을정제수, 에탄올, 글리세린등을 포함하는 혼합 용제, 기타 첨가제와 혼합하여 화장료 조성물을 제조하였다.A cosmetic composition was prepared by mixing the prepared mixture with a mixed solvent including purified water, ethanol, glycerin, and the like, and other additives.
<실험예 1> 항산화 효과 확인 : 잣나무 목재 및 케나프 혼합 추출물의 전자공여능 측정<Experimental Example 1> Confirmation of antioxidant effect: Measurement of electron donating ability of pine nut wood and kenaf mixed extract
상기 제조된 잣나무 목재 추출물 및 케나프 지상부 추출물의 혼합물의 항산화 효과를 확인하기 위해, 전자공여능을 측정하였다. 비교예로 잣나무 목재 추출물과 케나프 지상부 추출물을 단독으로 사용하였다.In order to confirm the antioxidant effect of the mixture of the above-prepared pine wood extract and the aerial part extract of Kenaf, the electron donating ability was measured. As a comparative example, pine wood extract and kenaf aerial part extract were used alone.
전자공여능(EDA: electron donating abilities)은 Blois의 방법을 변형하여 측정하였다. 1,1 -diphenyl-2-picrylhydrazyl (DPPH) 60 ㎕와 농도별 추출물을 120 ㎕씩 넣고 혼합한 후 15분간 방치한 다음 microplate reader를 이용하여 517 ㎚에서 흡광도를 측정하였다. 전자공여능은 시료용액의 첨가구와 무첨가구의 흡광도 감소율로 나타낸다.Electron donating abilities (EDA) were measured by modifying the method of Blois. After adding 60 μl of 1,1-diphenyl-2-picrylhydrazyl (DPPH) and 120 μl of each extract for each concentration, they were mixed and allowed to stand for 15 minutes. Then, the absorbance was measured at 517 nm using a microplate reader. The electron-donating ability is expressed as the rate of decrease in absorbance between the added and non-added portions of the sample solution.
전자공여능(%)= (1 - (시료첨가군의 흡광도/무첨가군의 흡광도)) ×100Electron donating ability (%) = (1 - (absorbance of sample added group/absorbance of non-added group)) × 100
도 1은, 잣나무 목재 추출물, 케나프 추출물 및 이들의 혼합물 전자공여능 측정 결과이다.1 is a result of measuring the electron donating ability of a cypress wood extract, a kenaf extract, and a mixture thereof.
도 1A는 잣나무 목재 추출물의 전자공여능 측정 결과이고, 도 1B는 케나프 추출물의 전자공여능 측정 결과이며, 도 1C는 혼합물의 전자공여능 측정 결과이다.1A is the result of measuring the electron donating ability of the pine nut extract, FIG. 1B is the result of measuring the electron donating ability of the kenaf extract, and FIG. 1C is the result of measuring the electron donating ability of the mixture.
도 1을 참조하면, 잣나무 목재 추출물, 케나프 줄기 추출물 및 이들의 혼합물의 전자공여능 측정 결과, 농도가 증가함에 따라 전자공여능이 증가하는 것을 확인할 수 있다. 또한, 잣나무 목재 추출물과 혼합물은 최고 농도인 1,000 ㎍/㎖에서 각각 91.6 %, 93.7 %의 효과를 나타내었고, 케나프 줄기 추출물은 100 ㎍/㎖에서 38.2 %의 효과를 나타냈지만 1,000 ㎍/㎖에서는 84.8 %의 효과를 나타내는 것을 확인할 수 있었다.Referring to FIG. 1, as a result of measuring the electron donating ability of the pine wood extract, the kenaf stem extract, and a mixture thereof, it can be seen that the electron donating ability increases as the concentration increases. In addition, the pine tree extract and the mixture showed 91.6% and 93.7% of the effect at the highest concentration of 1,000 μg/ml, respectively, and the kenaf stem extract showed an effect of 38.2% at 100 μg/ml, but at 1,000 μg/ml, It was confirmed that the effect was 84.8%.
<실험예 2> 항산화 효과 확인 : 잣나무 목재 및 케나프 혼합 추출물의 ABTS<Experimental Example 2> Confirmation of antioxidant effect: ABTS of pine tree wood and kenaf mixed extract ++ radical 소거능 검증 Verification of radical scavenging ability
상기 제조된 잣나무 목재 추출물 및 케나프 지상부 추출물의 혼합물의 항산화 효과를 확인하기 위해, ABTS+ radical 소거능을 확인하였다. 비교예로 잣나무 목재 추출물과 케나프 지상부 추출물을 단독으로 사용하였다.In order to confirm the antioxidant effect of the mixture of the above-prepared pine tree extract and the aerial part extract of kenaf, ABTS + radical scavenging activity was confirmed. As a comparative example, pine wood extract and kenaf aerial part extract were used alone.
ABTS+ radical scavenging activity assay는 인체 내에서 생성되는 radical을 대체하여 간접적으로 항산화능을 측정할 수 있는 in vitro 시험법이며 DPPH assay와 실험 원리는 동일하다.ABTS + radical scavenging activity assay is an in vitro test method that can measure antioxidant activity indirectly by replacing radicals generated in the human body, and the experimental principle is the same as DPPH assay.
7 mM 2,2-azino-bis(3-ethyl-benthiazoline-6-sulfonic acid)와 2.45 mM potassium persulfate를 혼합한 후 실온에서 24시간 방치하여 ABTS+ radical을 형성시킨 용액을 ethanol로 희석한 용액 100ul에 농도별 추출물 100 ㎕를 혼합하여 735 nm에서의 흡광도를 측정하였다.After mixing 7
ABTS radical 소거능은 하기 식에 의해 계산되었다.ABTS radical scavenging ability was calculated by the following formula.
ABTS radical 소거능(%) = (1 - (시료첨가군의 흡광도/무첨가군의 흡광도)) ×100ABTS radical scavenging ability (%) = (1 - (absorbance of sample added group / absorbance of non-added group)) × 100
도 2는, 잣나무 목재 추출물, 케나프 추출물 및 이들의 혼합물 ABTS radical 소거능 측정 결과이다.2 is a result of measuring the ABTS radical scavenging activity of a pine nut extract, a kenaf extract, and a mixture thereof.
도 2A는 잣나무 목재 추출물의 ABTS radical 소거능 측정 결과이고, 도 2B는 케나프 추출물의 ABTS radical 소거능 측정 결과이며, 도 2C는 혼합물의 ABTS radical 소거능 측정 결과이다.FIG. 2A is the result of measuring the ABTS radical scavenging activity of the pine nut extract, FIG. 2B is the result of measuring the ABTS radical scavenging activity of the kenaf extract, and FIG. 2C is the result of measuring the ABTS radical scavenging activity of the mixture.
도 2를 참조하면, 잣나무 목재 추출물, 케나프 줄기 추출물 및 이들의 혼합물의 ABTS 소거능을 측정한 결과, 잣나무 목재 추출물은 1,000 ㎍/㎖농도에서 90.8 %의 소거능을 보였으며, 케나프 줄기 추출물과 혼합물은 각각 1,000 ㎍/㎖ 농도에서 98.8 %, 99 %의 효과를 나타내어 ABTS 소거능이 우수함을 확인할 수 있다.Referring to FIG. 2, as a result of measuring the ABTS scavenging ability of pine nut wood extract, kenaf stem extract, and mixtures thereof, pine nut wood extract showed 90.8% scavenging ability at a concentration of 1,000 μg/ml, and kenaf stem extract and mixture showed an effect of 98.8% and 99% at a concentration of 1,000 μg/ml, respectively, confirming that the ABTS scavenging ability was excellent.
<실험예 3> 항산화 효과 확인 : 잣나무 목재 및 케나프 혼합 추출물의 SOD 유사활성 측정<Experimental Example 3> Confirmation of antioxidant effect: Measurement of SOD-like activity of pine nut wood and kenaf mixed extract
상기 제조된 잣나무 목재 추출물 및 케나프 지상부 추출물의 혼합물의 항산화 효과를 확인하기 위해, 농도별 시료용액 20 ul에 Tris-HCl 완충용액(50 mM Tris-HCl buffer, pH 8.5) 130 ㎕와 7.2 mM pyrogallol 20 ㎕를 가하여 혼합한 후 37 ℃에서 10분간 반응시켰다. 이후, 산화된 pyrogallol 양을 microplate reader를 이용하여 420 nm에서의 흡광도를 측정하였다.In order to confirm the antioxidant effect of the mixture of the above-prepared pine wood extract and kenaf aerial part extract, 130 μl of Tris-HCl buffer (50 mM Tris-HCl buffer, pH 8.5) and 7.2 mM pyrogallol were added to 20 μl of sample solution for each concentration. After adding and mixing 20 μl, the mixture was reacted at 37° C. for 10 minutes. Thereafter, the absorbance at 420 nm of the amount of oxidized pyrogallol was measured using a microplate reader.
SOD 유사활성은 하기 식에 의해 계산되었다.SOD-like activity was calculated by the following equation.
SOD 유사활성(%) = (1 - (시료첨가군의 흡광도/무첨가군의 흡광도)) ×100SOD-like activity (%) = (1 - (absorbance of sample added group / absorbance of non-added group)) × 100
도 3은, 잣나무 목재 추출물, 케나프 추출물 및 이들의 혼합물 SOD 유사활성 측정 결과이다.3 is a result of measuring SOD-like activities of pine nut extract, kenaf extract, and mixtures thereof.
도 3A는 잣나무 목재 추출물의 SOD 유사활성 측정 결과이고, 도 3B는 케나프 추출물의 SOD 유사활성 측정 결과이며, 도 3C는 혼합물의 SOD 유사활성 측정 결과이다.Fig. 3A is the measurement result of SOD-like activity of pine nut extract, Fig. 3B is the measurement result of SOD-like activity of kenaf extract, and Fig. 3C is the measurement result of SOD-like activity of the mixture.
도 3을 참조하면, 잣나무 목재 추출물, 케나프 줄기 추출물 및 이들의 혼합물의 SOD 유사활성을 측정한 결과, 잣나무 목재 추출물은 5 ㎍/㎖ 농도에서 1.91 %, 100 ㎍/㎖ 농도에서 3.81 %, 1000 ㎍/㎖에서 10.99 %의 활성을 나타내었고, 케나프 줄기 추출물은 5 ㎍/㎖ 농도에서 1.52 %, 100 ㎍/㎖ 농도에서 3.62 %, 1000 ㎍/㎖에서 7.56 %의 활성을 나타내었으며, 이들의 혼합물은 5 ㎍/㎖ 농도에서 0.95 %, 100 ㎍/㎖ 농도에서 2.28 %, 1000 ㎍/㎖에서 3.23 %의 활성을 나타내는 것을 확인할 수 있다.Referring to FIG. 3, as a result of measuring the SOD-like activity of pine nut wood extract, kenaf stem extract, and mixtures thereof, the pine wood extract was 1.91% at 5 μg/ml concentration, 3.81% at 100 μg/ml concentration, and 1000 The activity of 10.99% at μg/ml and the kenaf stem extract were 1.52% at 5 μg/ml, 3.62% at 100 μg/ml, and 7.56% at 1000 μg/ml. It can be seen that the mixture exhibits an activity of 0.95% at a concentration of 5 μg/ml, 2.28% at a concentration of 100 μg/ml, and 3.23% at a concentration of 1000 μg/ml.
<실험예 4> 미백 효과 확인 : Tyrosinase 저해율 측정<Experimental Example 4> Confirmation of whitening effect: Tyrosinase inhibition rate measurement
Tyrosinase는 멜라닌 합성 억제 기전에 핵심적인 역할을 하는 효소로써 tyrosine을 산소가 존재하는 곳에서 산화하여 멜라닌을 생성하며 추출물의 tyrosinase 억제 활성을 측정함으로써 미백 효능을 확인할 수 있다.Tyrosinase is an enzyme that plays a key role in the melanin synthesis inhibition mechanism. It oxidizes tyrosine in the presence of oxygen to produce melanin, and the whitening effect can be confirmed by measuring the tyrosinase inhibitory activity of the extract.
상기 제조된 잣나무 목재 추출물, 케나프 지상부 추출물 및 이들의 혼합물의 Tyrosinase 저해율은 Yagi 등의 방법에 따라 측정하였다. 시료용액 40 ㎕에 67 mM sodium phosphate buffer (pH 6.8) 80 ㎕와 10 mM L-DOPA 40 ㎕ 및 mushroom tyrosinase (200 U/㎖) 40 ㎕을 첨가하여 37 ℃에서 10 분간 반응시켜 반응액 중에 생성된 DOPA chrome을 475 nm에서 측정하였다. Tyrosinase inhibition rate of the above-prepared pine wood extract, kenaf aerial part extract, and mixtures thereof was measured according to the method of Yagi et al. To 40 μl of the sample solution, 80 μl of 67 mM sodium phosphate buffer (pH 6.8), 40 μl of 10 mM L-DOPA, and 40 μl of mushroom tyrosinase (200 U/ml) were added and reacted at 37 °C for 10 minutes. DOPA chrome was measured at 475 nm.
Tyrosinase 저해활성은 시료용액의 첨가구와 무첨가구의 흡광도 감소율로 나타내었다. Tyrosinase inhibitory activity was expressed as the rate of decrease in absorbance between the sample solution added and unadded.
Tyrosinase 저해율(%)= (1 - (시료첨가군의 흡광도/무첨가군의 흡광도)) ×100Tyrosinase inhibition rate (%) = (1 - (absorbance of sample added group / absorbance of non-added group)) × 100
도 4는, 잣나무 목재 추출물, 케나프 추출물 및 이들의 혼합물의 Tyrosinase 저해율 측정 결과이다.4 is a result of measuring Tyrosinase inhibition rate of pine wood extract, kenaf extract, and mixtures thereof.
도 4A는 잣나무 목재 추출물의 Tyrosinase 측정 결과이고, 도 4B는 케나프 추출물의 Tyrosinase 저해율 측정 결과이며, 도 4C는 혼합물의 Tyrosinase 저해율 측정 결과이다.Figure 4A is the Tyrosinase measurement result of the pine wood extract, Figure 4B is the Tyrosinase inhibition rate measurement result of the kenaf extract, and Figure 4C is the Tyrosinase inhibition rate measurement result of the mixture.
도 4를 참조하면, 잣나무 목재 추출물, 케나프 줄기 추출물 및 이들의 혼합물의 Tyrosinase 저해활성 측정 결과, 잣나무 목재 추출물은 최고 농도인 1,000 ㎍/㎖에서 40.9 %의 활성을 나타내었고, 케나프 줄기 추출물은 최고 농도인 1,000 ㎍/㎖에서 27.4 %의 활성을 나타내었으며, 혼합물은 1,000 ㎍/㎖에서 42.6 %의 저해활성을 보임을 확인할 수 있다. 즉, 추출물 모두 농도가 증가함에 따라 억제활성이 증가하는 것을 확인할 수 있었다.Referring to FIG. 4, as a result of measuring the Tyrosinase inhibitory activity of pine nut wood extract, kenaf stem extract, and mixtures thereof, pine nut wood extract showed 40.9% activity at the highest concentration of 1,000 μg/ml, and kenaf stem extract At the highest concentration of 1,000 μg/ml, the activity was 27.4%, and the mixture showed 42.6% inhibitory activity at 1,000 μg/ml. That is, it was confirmed that the inhibitory activity increased as the concentration of all extracts increased.
<실험예 5> 주름 개선 효과 확인 : Elastase 저해율 측정<Experimental Example 5> Confirmation of wrinkle improvement effect: Elastase inhibition rate measurement
상기 제조된 잣나무 목재 추출물, 케나프 지상부 추출물 및 이들의 혼합물의 Elastase 저해율은 Cannell방법을 변형하여 측정하였다. Elastase inhibition rate of the above-prepared pine wood extract, kenaf aerial part extract, and mixtures thereof was measured by modifying the Cannell method.
기질로서 N-succinyl-(L-Ala)3-p-nitroanilide를 사용하여 37 ℃에서 30분간 기질로부터 생성되는 p-nitroanilide의 생성량을 445 nm에서 측정하였다. 즉, 각 시험용액을 일정 농도가 되도록 조제하여 40 ㎕를 취하고, 50 mM tris-HCl buffer (pH 8.6)에 녹인 porcine pancreas elastase (0.5 U/㎖) 용액 40 ㎕와 0.4 M tris-HCl buffer (pH 8.6) 40 ㎕를 가하여 37 ℃에서 2 분간 가열한 후 기질로 50 mM tris-HCl buffer (pH 8.6)에 녹인 N-succinyl-(L-Ala)3-p-nitroanilide(3.2 mM)을 80 ㎕ 첨가하여 30 분간 반응시켜 측정하였다.Using N-succinyl-(L-Ala)3-p-nitroanilide as a substrate, the amount of p-nitroanilide generated from the substrate was measured at 445 nm at 37°C for 30 minutes. That is, 40 μl of each test solution was prepared to a certain concentration, and 40 μl of a solution of porcine pancreas elastase (0.5 U/ml) dissolved in 50 mM tris-HCl buffer (pH 8.6) and 0.4 M tris-HCl buffer (pH 8.6) were added. 8.6) After adding 40 μl and heating at 37 ° C for 2 minutes, 80 μl of N-succinyl-(L-Ala)3-p-nitroanilide (3.2 mM) dissolved in 50 mM tris-HCl buffer (pH 8.6) was added as a substrate. and reacted for 30 minutes to measure.
Elastase 저해율은 시료용액의 첨가구와 무첨가구의 흡광도 감소율로 나타내었다.Elastase inhibition rate was expressed as the rate of decrease in absorbance between the sample solution added and non-added.
Elastase 저해율(%)= (1 - (시료첨가군의 흡광도/무첨가군의 흡광도)) ×100Elastase inhibition rate (%) = (1 - (absorbance of sample added group / absorbance of non-added group)) × 100
도 5는, 잣나무 목재 추출물, 케나프 추출물 및 이들의 혼합물의 Elastase 저해율 측정 결과이다.5 is a result of measuring the Elastase inhibition rate of pine wood extract, kenaf extract, and mixtures thereof.
도 5A는 잣나무 목재 추출물의 Elastase 저해율 측정 결과이고, 도 5B는 케나프 추출물의 Elastase 저해율 측정 결과이며, 도 5C는 혼합물의 Elastase 저해율 측정 결과이다.FIG. 5A is the result of measuring the elastase inhibition rate of the pine nut extract, FIG. 5B is the result of measuring the elastase inhibition rate of the kenaf extract, and FIG. 5C is the result of measuring the elastase inhibition rate of the mixture.
도 5를 참조하면, 잣나무 목재 추출물은 10 ㎍/㎖ 농도에서 0.58 %, 100 ㎍/㎖ 농도에서 4.44 %, 1,000 ㎍/㎖에서 13.08 %의 활성을 나타내었고, 케나프 줄기 추출물은 10 ㎍/㎖ 농도에서 2.8 %, 100 ㎍/㎖ 농도에서 6.83 %, 1,000 ㎍/㎖에서 11.35 %의 활성을 나타내었으며, 이들의 혼합물은 10 ㎍/㎖ 농도에서 4.11 %, 100 ㎍/㎖ 농도에서 10.36 %, 1,000 ㎍/㎖에서 20.15 %의 활성을 나타내어 단일 추출물에 비해 높은 저해활성을 나타내었음을 확인할 수 있다.Referring to FIG. 5, the pine wood extract exhibited an activity of 0.58% at 10 μg/ml, 4.44% at 100 μg/ml, and 13.08% at 1,000 μg/ml, and the kenaf stem extract had an activity of 10 μg/ml. The activity was 2.8% at 100 μg/ml concentration, 6.83% at 100 μg/ml concentration, and 11.35% at 1,000 μg/ml. It can be confirmed that the extract exhibited an activity of 20.15% at ug/ml and exhibited higher inhibitory activity than that of a single extract.
<실험예 6> 수렴 및 모공수축 효과 확인<Experimental Example 6> Confirmation of convergence and pore contraction effect
상기 제조된 잣나무 목재 추출물, 케나프 지상부 추출물 및 이들의 혼합물의 피부수렴 활성은 Lee 등의 방법에 따라 측정하였다.The skin astringent activity of the above-prepared cypress wood extract, kenaf aerial part extract, and mixtures thereof was measured according to the method of Lee et al.
일정 농도가 되도록 조제한 시료용액 0.5 ㎖에 1X PBS에 녹인 0.5 % henoglobin 용액 0.5 ㎖를 첨가하여 1 분간 진탕혼합한 후 1,500 rpm에서 3 분간 원심 분리하였따. 이후 상등액 150 ㎕를 취하여 575 nm에서의 흡광도를 측정하였다. 피부수렴 활성은 시료용액의 첨가구와 무첨가구의 흡광도 감소율로 나타내었다.0.5 ml of a 0.5% henoglobin solution dissolved in 1X PBS was added to 0.5 ml of the sample solution prepared to a certain concentration, mixed with shaking for 1 minute, and then centrifuged at 1,500 rpm for 3 minutes. After taking 150 μl of the supernatant, the absorbance at 575 nm was measured. The skin astringent activity was expressed as the rate of decrease in absorbance between the sample solution added and non-added.
피부수렴활성(%)= (1 - (시료첨가군의 흡광도/무첨가군의 흡광도)) ×100Skin astringent activity (%) = (1 - (absorbance of sample added group / absorbance of non-added group)) × 100
도 6은, 잣나무 목재 추출물, 케나프 추출물 및 이들의 혼합물의 피부수렴 활성 측정 결과이다.6 is a result of measuring skin astringent activity of pine wood extract, kenaf extract, and mixtures thereof.
도 6A는 잣나무 목재 추출물의 피부수렴 활성 측정 결과이고, 도 6B는 케나프 추출물의 피부수렴 활성 측정 결과이며, 도 6C는 혼합물의 피부수렴 활성 측정 결과이다.Figure 6A is the result of measuring the skin astringent activity of the pine nut extract, Figure 6B is the result of measuring the skin astringent activity of the kenaf extract, and Figure 6C is the result of measuring the skin astringent activity of the mixture.
도 6을 참조하면, 잣나무 목재 추출물은 50 ㎍/㎖ 농도에서 8.57 %, 500 ㎍/㎖ 농도에서 47.53 %, 5,000 ㎍/㎖에서 68.4 %의 수렴활성을 나타내었고, 케나프 줄기 추출물은 100 ㎍/㎖ 농도에서 0.8 %, 500 ㎍/㎖ 농도에서 12.4 %, 5,000 ㎍/㎖에서 113.33 %의 수렴활성을 나타내었으며, 이들의 혼합물은 500 ㎍/㎖ 농도에서 4.25 %, 1,000 ㎍/㎖ 농도에서 22.16 %, 5,000 ㎍/㎖에서 111.51 %의 활성을 나타내는 것을 확인할 수 있었다.Referring to FIG. 6, the pine wood extract exhibited an astringent activity of 8.57% at a concentration of 50 μg/ml, 47.53% at a concentration of 500 μg/ml, and 68.4% at a concentration of 5,000 μg/ml, and the kenaf stem extract exhibited an astringent activity of 100 μg/ml. The astringent activity was 0.8% at ㎖ concentration, 12.4% at 500 ug/mL concentration, and 113.33% at 5,000 ug/mL concentration. , it was confirmed that the activity of 111.51% was exhibited at 5,000 μg/ml.
<실험예 7> 세포 독성 평가 : 세포 생존율 측정<Experimental Example 7> Cytotoxicity evaluation: cell viability measurement
1) 세포주 및 세포 배양1) Cell line and cell culture
본 실험에 이용한 melanoma 세포인 B16F10는 ATCC (USA)에서 구입하여 사용하였다. B16F10 세포의 배양은 10 % FBS와 1 % penicillin/streptomycin (100 U/㎖)을 첨가한 DMEM 배지를 사용하였으며, 37 ℃, 5 % CO incubator에 적응시켜 계대 배양하였다.B16F10, a melanoma cell used in this experiment, was purchased from ATCC (USA) and used. For the culture of B16F10 cells, DMEM medium supplemented with 10% FBS and 1% penicillin/streptomycin (100 U/ml) was used, and the cells were subcultured in a 37°C, 5% CO incubator.
2) MTT assay에 의한 세포 생존율 측정2) Measurement of cell viability by MTT assay
세포 생존율 측정은 멜라노마 세포 (B16F10)을 96 well plate에 1×105cells/well이 되도록 180 ㎕ 분주하였고, 시료를 농도별로 조제하여 20 ㎕ 첨가한 후 37 ℃, 5 % CO2 incubator에서 24 시간 배양하였다. 여기에 2.5 mg/㎖ 농도로 제조한 MTT 용액 40 ㎕ 를 첨가하여 4 시간 배양한 후 배양액을 제거하고 각 well당 DMSO 100 ㎕ 를 가하여 실온에서 10 분간 반응시킨 뒤 ELISA reader로 540 nm에서 흡광도를 측정하였다. To measure cell viability, 180 μl of melanoma cells (B16F10) were dispensed in a 96 well plate to be 1×105 cells/well, samples were prepared by concentration, 20 μl was added, and cultured for 24 hours in a 37 °C, 5% CO 2 incubator. did After adding 40 μl of MTT solution prepared at a concentration of 2.5 mg/ml and incubating for 4 hours, the culture medium was removed, 100 μl of DMSO was added to each well, reacted at room temperature for 10 minutes, and absorbance was measured at 540 nm with an ELISA reader. did
세포 생존율 측정은 시료용액의 첨가군과 무첨가군의 흡광도 감소율로 나타내었다. Cell viability was measured by the decrease in absorbance of the sample solution added group and non-added group.
세포 생존율(%) = (1 - (시료첨가군의 흡광도/무첨가군의 흡광도)) x 100Cell viability (%) = (1 - (absorbance of sample added group / absorbance of non-added group)) x 100
도 7은, 멜라노마 세포(B16F10)에서의 잣나무 목재 추출물 및 케나프 지상부 추출물 혼합물의 농도별 세포 생존율을 나타낸 것이다.Figure 7 shows the cell viability of a mixture of pine wood extract and kenaf aerial part extract according to concentration in melanoma cells (B16F10).
도 7을 참조하면, 혼합물은 1000 ㎍/㎖의 농도에서 97 %의 세포 생존율을 나타내는 것을 확인할 수 있다. Referring to Figure 7, it can be seen that the mixture exhibits a cell viability of 97% at a concentration of 1000 μg/ml.
따라서 이하의 멜라노마 세포에서의 미백관련 신호전달인자 측정은 생존율이 100 %에 가까운 농도인 25, 50, 100 ㎍/㎖의 농도에서 실험을 진행하였다.Therefore, the measurement of whitening-related signaling factors in the following melanoma cells was performed at concentrations of 25, 50, and 100 μg/ml, which are concentrations close to 100% viability.
<실험예 8> 미백 효과 및 염증 억제 효과 확인 : Western Blot을 통한 단백질 발현 측정<Experimental Example 8> Confirmation of whitening effect and anti-inflammatory effect: Protein expression measurement through Western Blot
혼합물이 melanin 합성에 관계된 인자인 MITF, TRP-1, TRP-2 및 tyrosinase에 미치는 mRNA 발현 억제 효과를 알아보기 위하여 B16F10 mouse melanoma cell에 25, 50, 100 ㎍/㎖의 추출물을 농도별로 처리한 후 control은 α-MSH를 처리하여 멜라닌을 과발현시키고, normal 부분에는 α-MSH를 처리하지 않는 구간으로 설정하였다. 24 시간 뒤에 RT-PCR으로 mRNA 발현을 측정하였으며, 이 때 세포의 여러 조건에서도 그 발현 정도의 차이가 거의 없는 house keeping gene인 GAPDH를 positive control로 사용하였다.In order to investigate the mRNA expression inhibitory effect of the mixture on MITF, TRP-1, TRP-2 and tyrosinase, which are factors related to melanin synthesis, B16F10 mouse melanoma cells were treated with 25, 50, and 100 μg/ml of the extract by concentration. The control was treated with α-MSH to overexpress melanin, and the normal part was set to a section where α-MSH was not treated. 24 hours later, mRNA expression was measured by RT-PCR, and at this time, GAPDH, a house keeping gene with little difference in expression level under various cell conditions, was used as a positive control.
구체적인 방법으로, MITF, TRP-1, TRP-2, tyrosinase의 미백관련 인자들의 활성을 알아보기 위하여 cell line (B16F10)을 100 mm tissue culture dish에 1×106 cells/well로 분주한 후 24시간 동안 배양하여 cell을 안정화시켰다. 배지를 제거한 후 α-MSH (100 nM)를 2시간 처리한 후 추출물을 농도 별로 처리한 배지로 24시간 배양한 후 다시 배지를 제거하고 1×PBS로 2번 세척해주었다. Complete mini 1 tab을 가한 100 ㎕ 로 RIPA buffer 10 ㎖에 용해하여 4 ℃, 13,200 rpm에서 20 분간 원심분리하였다. 원심분리하여 얻은 상층액은 BCA protein assay kit로 정량하였으며, 20 ㎕의 단백질을 10 % acryl amide gel에서 전기영동하여 분리하였다. 분리된 단백질은 transfer 기기를 이용하여 polyvinylidene fluoride (PVDF) membrane에 옮긴 다음 실온에서 1 시간동안 blocking buffer (5 % skim milk in TBST)에서 배양시켰다. 1차 항체를 희석하여 4 ℃에서 over night한 다음, 다시 10분 간격으로 tris-buffered saline and tween 20 (TBST)로 3회 세척하였다. 2차 항체를 1:1,000으로 희석하여 실온에서 2 시간 배양하였으며, TBST로 3회 세척한 후 Davinch-Chemi™ Imager CAS-400SM System를 이용하여 밴드 확인 및 정량하였다.In a specific way, in order to examine the activity of the whitening-related factors of MITF, TRP-1, TRP-2, and tyrosinase, the cell line (B16F10) was dispensed in a 100 mm tissue culture dish at 1×10 6 cells/well and then 24 hours Cells were stabilized by culturing for a period of time. After removing the medium, α-MSH (100 nM) was treated for 2 hours, and the extract was incubated for 24 hours with a medium treated by concentration, and then the medium was removed again and washed twice with 1 × PBS. 100 μl of Complete mini 1 tab was dissolved in 10 ml of RIPA buffer and centrifuged at 4° C. and 13,200 rpm for 20 minutes. The supernatant obtained by centrifugation was quantified with a BCA protein assay kit, and 20 μl of protein was separated by electrophoresis on a 10% acrylamide gel. The separated protein was transferred to a polyvinylidene fluoride (PVDF) membrane using a transfer device and then incubated in blocking buffer (5% skim milk in TBST) for 1 hour at room temperature. The primary antibody was diluted and incubated overnight at 4°C, then washed three times with tris-buffered saline and tween 20 (TBST) at 10-minute intervals. The secondary antibody was diluted 1:1,000, incubated at room temperature for 2 hours, washed three times with TBST, and bands were identified and quantified using the Davinch-Chemi™ Imager CAS-400SM System.
도 8은, 멜라노마 세포(B16F10)에서의 잣나무 목재 추출물 및 케나프 지상부 추출물 혼합물의 농도별 MITF, tyrosinase, TRP-1 및 TRP-2 단백질 발현량을 나타낸 것이다.Figure 8 shows the expression levels of MITF, tyrosinase, TRP-1 and TRP-2 proteins in melanoma cells (B16F10) by concentrations of a mixture of pine wood extract and kenaf aerial part extract.
도 8A는 멜라노마 세포(B16F10)에서의 잣나무 목재 추출물 및 케나프 지상부 추출물 혼합물의 농도별 MITF의 발현량을 나타낸 것이고, 도 8B는 멜라노마 세포(B16F10)에서의 잣나무 목재 추출물 및 케나프 지상부 추출물 혼합물의 농도별 tyrosinase의 발현량을 나타낸 것이고, 도 8C는 멜라노마 세포(B16F10)에서의 잣나무 목재 추출물 및 케나프 지상부 추출물 혼합물의 농도별 TRP-1 의 발현량을 나타낸 것이고, 도 8D는 멜라노마 세포(B16F10)에서의 잣나무 목재 추출물 및 케나프 지상부 추출물 혼합물의 농도별 TRP-2 의 발현량을 나타낸 것이다.Figure 8A shows the expression level of MITF at different concentrations of a mixture of pine nut wood extract and kenaf aerial part extract in melanoma cells (B16F10), and Fig. 8B shows pine nut wood extract and kenaf aerial part extract in melanoma cells (B16F10). Figure 8C shows the expression level of tyrosinase by concentration of the mixture, Figure 8C shows the expression level of TRP-1 by concentration of the mixture of pine wood extract and kenaf aerial part extract in melanoma cells (B16F10), Figure 8D is melanoma It shows the expression level of TRP-2 in cells (B16F10) at different concentrations of the mixture of pine wood extract and kenaf aerial part extract.
도 8을 참조하면, 잣나무 목재 추출물 및 케나프 지상부 추출물 혼합물을 25 ㎍/㎖, 50 ㎍/㎖, 100 ㎍/㎖의 농도별로 처리한 B16F10군에서 α-MSH에 의해 증가된 MITF, TRP-1, TRP-2 및 tyrosinase의 단백질 발현양이 감소된 것을 확인할 수 있었으며, 대조군인 kojic acid와 비교하였을 때 tyrosinase의 단백질 발현양에서 특히 유의한 결과를 확인할 수 있었다. Referring to FIG. 8, MITF and TRP-1 increased by α-MSH in the B16F10 group treated with a mixture of pine nut wood extract and kenaf aerial part extract at concentrations of 25 μg/ml, 50 μg/ml, and 100 μg/ml. , it was confirmed that the protein expression of TRP-2 and tyrosinase was reduced, and a particularly significant result was confirmed in the protein expression of tyrosinase when compared to the control kojic acid.
<실험예 9> 미백 효과 확인 : Reverse transcription-PCR을 통한 mRNA 발현 억제 측정<Experimental Example 9> Confirmation of whitening effect: mRNA expression inhibition measurement through reverse transcription-PCR
혼합 추출물이 melanin 합성에 관계된 인자인 MITF, TRP-1, TRP-2 및 tyrosinase에 미치는 mRNA 발현 억제 효과를 알아보기 위하여 B16F10 mouse melanoma cell에 25 ㎍/㎖, 50 ㎍/㎖, 100 ㎍/㎖의 추출물을 농도별로 처리한 후 control은 α-MSH를 처리하여 멜라닌을 과발현시키고, normal 부분에는 α-MSH를 처리하지 않는 구간으로 설정하였다. 24 시간 뒤에 RT-PCR으로 mRNA 발현을 측정하였으며, 이 때 세포의 여러 조건에서도 그 발현 정도의 차이가 거의 없는 house keeping gene인 GAPDH를 positive control로 사용하였다.In order to investigate the mRNA expression inhibitory effect of the mixed extract on MITF, TRP-1, TRP-2 and tyrosinase, which are factors related to melanin synthesis, 25 μg/ml, 50 μg/ml, and 100 μg/ml of B16F10 mouse melanoma cells were tested. After processing the extract by concentration, the control was treated with α-MSH to overexpress melanin, and the normal part was set to a section not treated with α-MSH. 24 hours later, mRNA expression was measured by RT-PCR, and at this time, GAPDH, a house keeping gene with little difference in expression level under various cell conditions, was used as a positive control.
실험에 사용한 primer sequences는 Table 1과 같다. PCR tube에 5×green Go Taq Flexi buffer, MgCl2, PCR Nucleotide Mix (10 mM), primer, Go Taq DNA Polymerase, nuclease free water,합성한 cDNA를 첨가하여 잘 섞은 후 PCR을 실행하였다. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH)는 96 ℃에서 10 초, 64℃에서 30 초, 72 ℃에서 1 분 (40 cycles)를 하였으며, Tyrosinase는 96 ℃ 10 초, 64 ℃ 30 초, 72 ℃ 1 분 (40 cycles)를 하였다. MITF, TRP-1, TRP-2는 각각 96 ℃ 10 초, 56 ℃ 30 초, 72 ℃ 1 분 (40 cycles)를 하였다. PCR로 합성시킨 후 0.002 % ethidium bromide가 첨가한 1.5 % agarose gel에 100 V에서 30분간 전기영동 후 UV transilluminator을 이용하여 밴드를 확인하여 분석 정량하였다.The primer sequences used in the experiment are shown in Table 1. 5 × green Go Taq Flexi buffer, MgCl2, PCR Nucleotide Mix (10 mM), primer, Go Taq DNA Polymerase, nuclease free water, and synthesized cDNA were added to the PCR tube, mixed well, and then PCR was performed. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was 96 ℃ for 10 seconds, 64 ℃ for 30 seconds, 72
표1은 RT-PCR에 사용된 프라이머 시퀀스이다.Table 1 shows the primer sequences used for RT-PCR.
MMP-2
MMP-3
도 9는, 멜라노마 세포(B16F10)에서의 잣나무 목재 추출물 및 케나프 지상부 추출물 혼합물의 농도별 MITF, TRP-1, TRP-2 및 tyrosinase mRNA 발현량을 나타낸 것이다.9 shows the expression levels of MITF, TRP-1, TRP-2, and tyrosinase mRNA in melanoma cells (B16F10) by concentrations of a mixture of pine wood extract and kenaf aerial part extract.
도 9A는 멜라노마 세포(B16F10)에서의 잣나무 목재 추출물 및 케나프 지상부 추출물 혼합물의 농도별 MITF mRNA 의 발현량을 나타낸 것이고, 도 9B는 멜라노마 세포(B16F10)에서의 잣나무 목재 추출물 및 케나프 지상부 추출물 혼합물의 농도별 tyrosinase mRNA 의 발현량을 나타낸 것이고, 도 9C는 멜라노마 세포(B16F10)에서의 잣나무 목재 추출물 및 케나프 지상부 추출물 혼합물의 농도별 TRP-1 mRNA 의 발현량을 나타낸 것이고, 도 10D는 멜라노마 세포(B16F10)에서의 잣나무 목재 추출물 및 케나프 지상부 추출물 혼합물의 농도별 TRP-2 mRNA 의 발현량을 나타낸 것이다.Figure 9A shows the expression level of MITF mRNA at different concentrations of the mixture of pine nut wood extract and kenaf aerial part extract in melanoma cells (B16F10), and Fig. 9B shows the expression level of pine nut wood extract and kenaf aerial part in melanoma cells (B16F10). Figure 9C shows the expression level of tyrosinase mRNA for each concentration of the extract mixture, and Figure 9C shows the expression level of TRP-1 mRNA for each concentration of the mixture of pine wood extract and kenaf aerial part extract in melanoma cells (B16F10), Figure 10D shows the expression level of TRP-2 mRNA in melanoma cells (B16F10) at different concentrations of the mixture of pine wood extract and kenaf aerial part extract.
도 9를 참조하면, 잣나무 목재 추출물 및 케나프 지상부 추출물 혼합물을 25 ㎍/㎖, 50 ㎍/㎖, 100 ㎍/㎖의 농도별로 처리한 B16F10 군 control 부분에서는 mRNA가 과발현하였고, MITF, TRP-1, TRP-2 및 tyrosinase의 mRNA 발현 측정 결과 농도가 증가함에 따라서 mRNA 발현을 억제하였고 대조군인 kojic acid와 비교했을 때 특히 TRP-2과 tyrosinase의 발현 억제의 유의한 결과를 확인할 수 있었다.Referring to FIG. 9, mRNA was overexpressed in the control part of the B16F10 group treated with a mixture of pine nut wood extract and kenaf aerial part extract at concentrations of 25 μg/ml, 50 μg/ml, and 100 μg/ml, and MITF and TRP-1 As a result of measuring the mRNA expression of TRP-2 and tyrosinase, the mRNA expression was suppressed as the concentration increased, and when compared to the control group, kojic acid, the expression of TRP-2 and tyrosinase was significantly suppressed.
이상과 같이 실시예들이 비록 한정된 도면에 의해 설명되었으나, 해당 기술분야에서 통상의 지식을 가진 자라면 상기를 기초로 다양한 기술적 수정 및 변형을 적용할 수 있다. 예를 들어, 설명된 기술들이 설명된 방법과 다른 순서로 수행되거나, 및/또는 설명된 시스템, 구조, 장치, 회로 등의 구성요소들이 설명된 방법과 다른 형태로 결합 또는 조합되거나, 다른 구성요소 또는 균등물에 의하여 대치되거나 치환되더라도 적절한 결과가 달성될 수 있다.As described above, although the embodiments have been described with limited drawings, those skilled in the art can apply various technical modifications and variations based on the above. For example, the described techniques may be performed in an order different from the method described, and/or components of the described system, structure, device, circuit, etc. may be combined or combined in a different form than the method described, or other components may be used. Or even if it is replaced or substituted by equivalents, appropriate results can be achieved.
그러므로, 다른 구현들, 다른 실시예들 및 특허청구범위와 균등한 것들도 후술하는 청구범위의 범위에 속한다.Therefore, other implementations, other embodiments, and equivalents of the claims are within the scope of the following claims.
Claims (13)
화장료 조성물.
Containing a mixture of a pine tree ( Pinus koraiensis ) wood extract and a kenaf ( Hibiscus cannabinus ) extract as an active ingredient,
cosmetic composition.
상기 잣나무 목재 추출물 및 상기 케나프 추출물의 중량비는,
1 : 10 내지 10 : 1인 것인,
화장료 조성물.
According to claim 1,
The weight ratio of the pine wood extract and the kenaf extract is
1: 10 to 10: 1,
cosmetic composition.
상기 혼합물은,
상기 화장료 조성물 전체 중, 0.1 중량% 내지 50 중량%로 포함되는 것인,
화장료 조성물.
According to claim 1,
The mixture is
Of the total cosmetic composition, contained in 0.1% to 50% by weight,
cosmetic composition.
상기 추출물은,
물, 탄소수 1 내지 4의 저급 알코올, 아세톤, 에틸아세테이트, 클로로포름, 1,3-부틸렌글리콜, n-헥산, 디에틸에테르, 부틸아세테이트 및 디클로로메탄으로 이루어진 군에서 선택되는 하나 이상을 추출 용매로 하여 추출된 것인,
화장료 조성물.
According to claim 1,
The extract is
At least one selected from the group consisting of water, lower alcohols having 1 to 4 carbon atoms, acetone, ethyl acetate, chloroform, 1,3-butylene glycol, n-hexane, diethyl ether, butyl acetate and dichloromethane as an extraction solvent which is extracted by
cosmetic composition.
상기 추출은,
1 ℃ 내지 40 ℃의 온도에서 4 시간 내지 60 시간 동안 수행되는 것인,
화장료 조성물.
According to claim 4,
The extraction is
Which is carried out for 4 hours to 60 hours at a temperature of 1 ℃ to 40 ℃,
cosmetic composition.
1,1 -디페닐-2-피크릴하이드라질(1,1 -diphenyl-2-picrylhydrazyl, DPPH) 라디칼 소거능, 2,2'-아지노비스-(3-에틸벤조티아졸린-6-설폰산)(2,2'-Azinobis-(3-ethylbenzothiazoline-6-sulfonic acid, ABTS) 라디칼 소거능 또는 SOD(superoxide dismutase) 유사활성을 갖는 것인,
화장료 조성물.
According to claim 1,
1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging activity, 2,2'-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) (2,2'-Azinobis-(3-ethylbenzothiazoline-6-sulfonic acid, ABTS) having radical scavenging activity or SOD (superoxide dismutase)-like activity,
cosmetic composition.
MITF(microphthalmia associated transcription factor) 발현 억제, TRP-1(tyrosinase related protein-1) 발현 억제, TRP-2(tyrosinase related protein-2) 발현 억제, 티로시나아제(Tyrosinase) 활성 저해 및 엘라스타제(elastase) 활성 저해 중 적어도 하나 이상의 성능을 갖는 것인,
화장료 조성물.
According to claim 1,
Inhibition of microphthalmia associated transcription factor (MITF) expression, inhibition of tyrosinase related protein-1 (TRP-1) expression, inhibition of tyrosinase related protein-2 (TRP-2) expression, inhibition of tyrosinase activity and elastase ) having at least one performance of activity inhibition,
cosmetic composition.
잣나무(Pinus koraiensis) 잎 에탄올 추출물을 유효성분으로 더 포함하는 것인,
화장료 조성물.
According to claim 1,
Pine tree ( Pinus koraiensis ) Which further comprises leaf ethanol extract as an active ingredient,
cosmetic composition.
상기 혼합물 100 중량부에 대하여, 상기 잣나무 잎 에탄올 추출물은 10 중량부 내지 100 중량부로 포함되는 것인,
화장료 조성물.
According to claim 8,
Based on 100 parts by weight of the mixture, the pine nut leaf ethanol extract is contained in 10 parts by weight to 100 parts by weight,
cosmetic composition.
병풀 추출물, 프로폴리스 추출물, 어성초 추출물, 녹차잎 추출물, 맥문동 추출물 및 구기자 추출물로 이루어진 군에서 선택되는 하나 이상의 식물성 추출물을 유효 성분으로 더 포함하는 것인,
화장료 조성물.
According to claim 1,
Further comprising, as an active ingredient, at least one vegetable extract selected from the group consisting of centella asiatica extract, propolis extract, houttuynia cordata extract, green tea leaf extract, vermiculite extract, and goji berry extract,
cosmetic composition.
상기 혼합물 100 중량부에 대하여, 상기 식물성 추출물은 1 중량부 내지 30 중량부로 포함되는 것인,
화장료 조성물.
According to claim 10,
With respect to 100 parts by weight of the mixture, the vegetable extract is contained in 1 part by weight to 30 parts by weight,
cosmetic composition.
상기 화장료 조성물은,
항산화용, 미백용, 주름개선용, 수렴용, 모공수축용 또는 염증 억제용인 것인,
화장료 조성물.
According to claim 1,
The cosmetic composition,
For antioxidant, whitening, wrinkle improvement, convergence, pore contraction or inflammation inhibition,
cosmetic composition.
상기 화장료는,
화장수, 토너, 스킨, 로션, 에멀젼, 크림, 에센스, 세럼, 젤 및 팩으로 이루어지는 군으로부터 선택되는 어느 하나인 기초 화장료, 립스틱, 틴트, 립글로우, 립밤, 비비크림, 파운데이션, 파우더, 마스카라, 아이쉐도우 및 아이라이너로부터 선택되는 메이크업 화장료,
피부각질 스크럽, 클렌징워터, 클렌징오일, 클렌징크림 및 폼클렌징으로 이루어지는 군으로부터 선택되는 어느 하나인 세정용 화장료,
샴푸, 린스 및 트리트먼트로 이루어지는 군으로부터 선택되는 어느 하나인 모발용 화장료, 및
바디스크럽, 바디로션, 바디크림, 및 바디워시로 이루어지는 군으로부터 선택되는 어느 하나인 바디용 화장료,
로 이루어지는 군으로부터 선택되는 하나 이상을 포함하는 것인,
화장료 조성물.According to claim 1,
The cosmetics,
Any one of basic cosmetics selected from the group consisting of lotion, toner, skin, lotion, emulsion, cream, essence, serum, gel and pack, lipstick, tint, lip glow, lip balm, BB cream, foundation, powder, mascara, eye Make-up cosmetics selected from shadows and eyeliners;
A cosmetic for washing, which is any one selected from the group consisting of dead skin scrub, cleansing water, cleansing oil, cleansing cream, and foam cleansing,
A cosmetic for hair that is any one selected from the group consisting of shampoo, rinse and treatment, and
Any one cosmetic for body selected from the group consisting of body scrub, body lotion, body cream, and body wash;
To include one or more selected from the group consisting of,
cosmetic composition.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210105234A KR20230023267A (en) | 2021-08-10 | 2021-08-10 | Cosmetic composition comprising mixed extrracts of pinus koraiensis wood and kenaf |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210105234A KR20230023267A (en) | 2021-08-10 | 2021-08-10 | Cosmetic composition comprising mixed extrracts of pinus koraiensis wood and kenaf |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20230023267A true KR20230023267A (en) | 2023-02-17 |
Family
ID=85327402
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210105234A KR20230023267A (en) | 2021-08-10 | 2021-08-10 | Cosmetic composition comprising mixed extrracts of pinus koraiensis wood and kenaf |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20230023267A (en) |
-
2021
- 2021-08-10 KR KR1020210105234A patent/KR20230023267A/en not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102088728B1 (en) | Cosmetic Composition for Improving Skin Elasticity and Winkles Comprising Plant Complex Extracts as Active Ingredient | |
KR101243219B1 (en) | Skin whitening and anti-wrinkle composition comprising a fermented plant extract in Ulleung island | |
KR20160121074A (en) | A composition comprising an seed extract of Vitex trifolia L. for skin whitening and anti-aging activity | |
KR100535875B1 (en) | Cosmetic composition comprising the extract of complex herb showing skin anti-aging and whitening effect | |
KR101458013B1 (en) | Composition for anti-oxidation and whitening and anti-wrinkle cosmetics comprising extract of un-ripening Pinus koraiensis Siebold et Zucc cone | |
KR20130049040A (en) | Cosmetic composition including taxifolin glucosides and extracting method of paeonia lactiflora extracts | |
KR101243220B1 (en) | Skin whitening and anti-wrinkle composition comprising a fermented plant extract in Ulleung island | |
US11331265B2 (en) | Ultraviolet blocking agent and cosmetic product | |
KR20080097636A (en) | Composition comprising an extract of cornus kousa or the compounds isolated therefrom having anti-aging and anti-wrinkle activity | |
KR20210134589A (en) | Composition for improving skin comprising an extract of Pueraria thomsonii or a compound derived therefrom | |
KR101230588B1 (en) | Cosmetics Composite | |
KR20230023267A (en) | Cosmetic composition comprising mixed extrracts of pinus koraiensis wood and kenaf | |
KR102054132B1 (en) | Composition comprising extract of Prasiola japonica for skin whitening | |
KR102636105B1 (en) | Cosmetic composition including extract of rhododendron brachycarpum or extract of rhododendron fortunei | |
KR100829831B1 (en) | A skin whitening compositions comprising natural plant extract | |
KR100756669B1 (en) | Cosmetic composition comprising an extract of Persicae fructus having whitening activities | |
KR101570123B1 (en) | Cosmetic Composition Comprising Extract of testa of Pinus koraiensis Siebold et Zucc | |
KR102659128B1 (en) | Cosmetic composition comprising dogo hot spring water | |
KR20230009017A (en) | Cosmetic composition containing extracts of above-ground parts of glechoma grandis | |
KR102394459B1 (en) | A whitening composition comprising youngia sonchifolia extract | |
KR102326086B1 (en) | Composition for Improving Skin Conditions Having Skin Whitening, Moisturizing, Anti-Wrinkle and Skin Barrier Property Comprising Complex Extracts of Broussonetia kazinoki as Active Ingredient | |
KR102017078B1 (en) | Cosmetic composition for skin whitening of poria cocos culture extract using japanese apricot | |
KR101774860B1 (en) | A Cosmetic Composition for Whitening or Pore-Minimizing Comprising Extract of testa of Pinus koraiensis Siebold et Zucc | |
KR20240047133A (en) | Cosmetic composition comprising probiotics cultivatied using hot spring water and plant complex extract as active ingredient | |
KR100750186B1 (en) | Cosmetic composition comprising the extract of Maakia fauriei showing anti-oxidation and skin whitening activity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal |